Diplopia

H7_DIPLOPIA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H53.2 Hospital discharge: ICD-9 — 3682 Cause of death: ICD-10 — H53.2 Cause of death: ICD-9 — 3682 2 out of 7 registries used, show all original rules.	5332
4. Check minimum number of events None	5332
5. Include endpoints None	5332
6. Filter based on genotype QC (FinnGen only)	5332

Control definitions (FinnGen only)

Control exclude: H7_VISUALDISTBLIND

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H53
Name in latin: Diplopia

NAME	H7_DIPLOPIA
CONTROL_EXCLUDE	H7_VISUALDISTBLIND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H532
HD_ICD_9	3682
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H532
COD_ICD_9	3682
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diplopia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	31915	16114	15679
Only index persons	29817	15235	14582
Unadjusted period prevalence (%)
Whole population	0.45	0.46	0.44
Only index persons	0.56	0.56	0.56
Median age at first event (years)
Whole population	58.10	57.83	58.33
Only index persons	57.67	57.47	57.89

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5332	2951	2381
Unadjusted period prevalence (%)	1.03	1.01	1.05
Median age at first event (years)	58.55	55.64	62.14

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4739: Matched controls
47391

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H53.1

ICD-10 Finland

Subjective visual disturbances

20.8

323.0

625

344

XCW99

NOMESCO Finland

Other investigative procedure of eye

5.6

323.0

1128

2495

H53.2

ICD-10 Finland

Diplopia

4503599627370496.0

323.0

4694

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

61.8

323.0

418

AA1AD

NOMESCO Finland

CT of head and brain

3.7

322.1

1829

6825

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.8

260.7

820

1656

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

47.2

221.1

272

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.6

220.2

1205

4132

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.1

218.3

766

1731

XCK00

NOMESCO Finland

Perimetry

5.7

206.1

644

1268

H50.2

ICD-10 Finland

Vertical strabismus

34.1

186.6

246

R51.80

ICD-10 Finland

Headache

3.3

166.1

1002

3603

R42

ICD-10 Finland

Dizziness and giddiness

2.7

154.2

1333

6026

TAB00

NOMESCO Finland

Lumbar puncture

6.1

147.6

429

759

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

47.3

145.0

178

H50.52

ICD-10 Finland

Exophoria

18.7

137.0

215

120

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.7

131.0

629

1863

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

7.3

119.7

303

441

H53.4

ICD-10 Finland

Visual field defects

46.8

114.8

141

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

109.4

2224

14512

G35

ICD-10 Finland

Multiple sclerosis

10.1

100.3

206

212

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.2

97.0

572

1960

CE2W4

NOMESCO Finland

Eye movement mapping

97.6

95.3

105

G70.0

ICD-10 Finland

Myasthenia gravis

36.0

94.9

123

H50.0

ICD-10 Finland

Convergent concomitant strabismus

23.9

94.9

137

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.9

93.1

626

2343

N07AA02

ATC

pyridostigmine; systemic

24.4

92.8

133

H53.9

ICD-10 Finland

Visual disturbance, unspecified

8.5

88.4

201

247

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

18.0

85.3

135

109

Kela drug reimbursment

Multiple sclerosis

11.9

82.4

155

134

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

14.0

82.3

144

106

N03AX12

ATC

gabapentin; oral

2.3

81.9

856

4090

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.1

79.9

490

1715

H50.31

ICD-10 Finland

Intermittent exotropia

15.2

77.0

130

N03AX16

ATC

pregabalin; oral

2.0

76.3

1190

6760

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

13.2

74.9

134

104

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

6.5

74.8

204

328

F05

ICPC

Visual disturbance other

5.7

74.0

222

403

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

4.3

73.4

292

719

G44.2

ICD-10 Finland

Tension-type headache

2.4

71.2

692

3168

H50.1

ICD-10 Finland

Divergent concomitant strabismus

15.0

70.8

120

H50.51

ICD-10 Finland

Esophoria

22.9

70.7

103

108

Kela drug reimbursment

Myasthenia gravis

31.6

69.8

CEC00

NOMESCO Finland

Recession of extraocular muscle

25.0

69.1

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

68.8

1900

13070

N02BE01

ATC

paracetamol; systemic, rectal

2.0

68.2

4012

34850

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

16.2

67.7

111

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.2

67.1

385

1281

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

5.3

67.0

216

427

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

15.5

66.6

111

B01AC04

ATC

clopidogrel; oral

2.2

65.5

810

4141

A02BC02

ATC

pantoprazole; systemic

1.7

63.7

2984

23752

N02AX02

ATC

tramadol; systemic, rectal

1.7

62.3

1987

14138

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.2

61.8

350

1152

H04.10

ICD-10 Finland

Dry eye syndrome

2.5

61.8

525

2229

S06.0

ICD-10 Finland

Concussion

2.5

61.2

551

2412

N03AX09

ATC

lamotrigine; oral

3.6

60.4

291

846

H50.30

ICD-10 Finland

Intermittent esotropy

38.1

58.9

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

57.9

822

4434

XA800

NOMESCO Finland

Neuropsychological investigation

3.7

56.9

262

734

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.8

56.8

401

1527

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.8

55.1

190

405

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

4.3

54.2

210

503

H02AB06

ATC

prednisolone; systemic

1.6

52.5

2140

16020

R53

ICD-10 Finland

Malaise and fatigue

1.9

52.4

971

5756

3682A

ICD-9 Finland

Visual disturbances, Diplopia

+∞

52.2

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

52.1

453

1938

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

51.7

1594

11061

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.8

51.0

348

1295

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

50.2

1004

6099

R06.0

ICD-10 Finland

Dyspnoea

1.8

49.8

1153

7340

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

13.2

49.5

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

48.7

1330

8883

R20.2

ICD-10 Finland

Paraesthesia of skin

2.7

47.8

347

1339

M79.6

ICD-10 Finland

Pain in limb

1.6

46.7

1586

11220

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

46.5

739

4127

L03AB07

ATC

interferon beta-1a; parenteral

14.0

46.3

N06AX11

ATC

mirtazapine; oral

1.6

45.9

1405

9653

N06AX16

ATC

venlafaxine; oral

2.0

45.3

635

3377

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

8.1

44.0

101

127

N17

ICPC

Vertigo/dizziness

2.1

43.2

534

2691

J01DB01

ATC

cefalexin; oral

1.6

43.0

3693

32427

WX110

NOMESCO Finland

Local anesthesy

1.5

42.6

3058

25653

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

42.0

1214

8173

N03AG01

ATC

valproic acid; systemic, rectal

2.6

41.8

316

1248

N01

ICPC

Headache

2.2

41.7

475

2310

N05CF01

ATC

zopiclone; oral

1.6

41.5

1422

10008

H57.1

ICD-10 Finland

Ocular pain

3.8

41.2

184

502

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

3.8

41.2

183

497

M54.5

ICD-10 Finland

Low back pain

1.6

41.1

1424

10043

N05AH04

ATC

quetiapine; oral

1.9

41.1

729

4221

H53.3

ICD-10 Finland

Other disorders of binocular vision

29.3

40.8

A04

ICPC

Weakness/tiredness general

2.0

40.7

615

3359

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

40.4

1224

8328

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

40.0

562

2982

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.9

39.9

256

913

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

39.8

1310

9103

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

39.7

960

6127

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

39.4

270

1004

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.5

38.5

309

1262

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

16.5

38.5

R03AC02

ATC

salbutamol; inhalant

1.5

38.4

2270

18041

N03AE01

ATC

clonazepam; systemic

2.6

38.2

303

1228

CS494

NOMESCO Finland

Other visual field testing

4.4

38.0

143

334

N06AX21

ATC

duloxetine; oral

2.1

38.0

490

2511

G51.0

ICD-10 Finland

Bell palsy

3.8

37.7

164

438

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

37.5

1613

11924

H51.1

ICD-10 Finland

Convergence insufficiency and excess

22.7

37.4

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

4.8

36.7

127

273

R4110

NOMESCO Finland

Physiotherapy

1.6

36.6

1179

8117

C07AA05

ATC

propranolol; systemic

1.7

36.4

830

5190

A02BC05

ATC

esomeprazole; systemic

1.5

36.1

1746

13219

M25.5

ICD-10 Finland

Pain in joint

1.6

36.0

1205

8367

ZXA10

NOMESCO Finland

Bilateral

1.7

35.6

850

5382

L03AX13

ATC

glatiramer acetate; parenteral

12.8

35.2

H02.4

ICD-10 Finland

Ptosis of eyelid

3.5

35.0

172

508

C07AB07

ATC

bisoprolol; oral

1.5

35.0

2027

15923

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4.2

34.8

135

325

N05BA04

ATC

oxazepam; oral

1.6

34.8

1067

7234

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

34.8

717

4340

N06AB04

ATC

citalopram; systemic

1.7

34.7

946

6215

H53.0

ICD-10 Finland

Amblyopia ex anopsia

47.0

34.7

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

34.6

475

2493

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

5.9

34.4

172

S18

ICPC

Laceration/cut

1.5

34.4

1813

13944

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

34.3

815

5148

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

57.6

34.2

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

34.1

1390

10093

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

34.1

1995

15675

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

34.0

634

3713

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

34.0

539

2983

H46

ICD-10 Finland

Optic neuritis

8.8

33.7

L28

ICPC

Limited function/disability (L)

1.8

33.7

686

4135

C10AA05

ATC

atorvastatin; oral

1.5

33.6

1629

12288

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

33.5

250

977

H03AA01

ATC

levothyroxine sodium; systemic

1.6

33.5

999

6715

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.8

33.2

168

PA7BD

NOMESCO Finland

CT angiography of neck and brain

4.4

32.9

123

286

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

32.9

1740

13354

M03BX02

ATC

tizanidine; oral

1.4

32.7

2627

21912

A28

ICPC

Limited function/disability NOS

1.8

32.4

658

3957

R02

ICPC

Shortness of breath/dyspnoea

1.9

32.3

546

3090

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

9.7

32.2

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

21.6

32.1

CEW99

NOMESCO Finland

Other operation on extraocular muscle

40.4

32.1

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.5

31.8

154

450

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

31.5

873

5745

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

31.3

215

801

N06AB10

ATC

escitalopram; oral

1.7

31.2

813

5257

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.1

31.2

392

1981

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

31.2

2331

19094

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

5.6

31.1

166

R51

ICD-10 Finland

Headache

2.5

31.1

252

1033

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

31.0

361

1764

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

30.9

550

3167

N03AF02

ATC

oxcarbazepine; oral

3.1

30.7

172

561

UJF32

NOMESCO Finland

Coloscopy

1.6

30.7

1103

7741

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

30.7

253

1045

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.5

30.5

253

1052

H50.9

ICD-10 Finland

Strabismus, unspecified

20.6

30.4

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

13.4

30.4

J01MA02

ATC

ciprofloxacin; systemic

1.5

30.4

1663

12798

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

30.3

670

4129

M79.1

ICD-10 Finland

Myalgia

1.8

30.2

528

3019

L03

ICPC

Low back symptom/complaint

1.6

30.1

1009

6961

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

18.6

30.0

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

29.9

684

4256

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

29.9

1017

7038

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

29.8

1414

10551

H53.8

ICD-10 Finland

Other visual disturbances

7.5

29.7

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

29.7

437

2350

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

8.8

29.6

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

29.6

530

3055

L17

ICPC

Foot/toe symptom/complaint

1.6

29.5

1052

7357

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

29.3

752

4835

UKC02

NOMESCO Finland

Cystoscopy

1.7

29.1

706

4466

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

8.7

29.1

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

29.0

694

4376

R13

ICD-10 Finland

Dysphagia

2.2

28.9

314

1487

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

28.9

476

2664

N05BA01

ATC

diazepam; systemic, rectal

1.8

28.8

581

3478

K02.1

ICD-10 Finland

Caries of dentine

1.4

28.7

2370

19655

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.8

28.7

535

3125

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

33.9

28.7

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

28.6

293

1353

A02BC01

ATC

omeprazole; systemic

1.5

28.5

1173

8471

N06AA09

ATC

amitriptyline; systemic

1.9

28.4

452

2500

R55

ICD-10 Finland

Syncope and collapse

1.8

28.1

490

2796

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.4

28.1

240

1011

L04AX07

ATC

dimethyl fumarate; oral

15.5

28.1

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

5.5

27.8

156

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

27.6

586

3562

H50.8

ICD-10 Finland

Other specified strabismus

35.2

27.4

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

27.4

2971

25781

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.0

27.2

164

563

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

27.2

334

1671

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

27.0

2129

17426

ZXA05

NOMESCO Finland

Left side

1.5

27.0

1079

7726

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

26.9

1592

12358

N06AB03

ATC

fluoxetine; oral

1.8

26.9

534

3176

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

26.9

1704

13404

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

26.7

1180

8635

N02AA05

ATC

oxycodone; systemic

1.7

26.6

619

3865

H02AB07

ATC

prednisone; oral

1.7

26.5

617

3850

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

26.4

670

4284

WX002

NOMESCO Finland

Sedation and analgesia

1.6

26.1

839

5703

L03AB08

ATC

interferon beta-1b; parenteral

14.3

26.1

N03AX11

ATC

topiramate; oral

3.4

26.1

132

401

Z71.8

ICD-10 Finland

Other specified counselling

1.5

25.8

967

6815

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

25.8

1212

8971

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.5

25.6

206

842

H52.5

ICD-10 Finland

Disorders of accommodation

21.9

25.6

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.7

25.5

180

681

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

25.5

367

1954

C10AA01

ATC

simvastatin; oral

1.4

25.4

1794

14346

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

25.1

857

5906

SPAT1263

SPAT

Sampling

1.4

25.1

1834

14750

N04BC05

ATC

pramipexole; oral

2.0

25.0

328

1682

N03AF01

ATC

carbamazepine; oral, rectal

2.3

25.0

242

1088

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.3

24.9

131

410

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

24.8

1195

8879

C03CA01

ATC

furosemide; systemic

1.5

24.8

1171

8665

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.1

24.8

139

456

H03BB01

ATC

carbimazole; oral

2.6

24.4

188

751

J01FF01

ATC

clindamycin; systemic

1.5

24.3

1118

8218

CEC30

NOMESCO Finland

Resection of extraocular muscle

22.0

24.3

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.1

24.3

136

446

M03BX01

ATC

baclofen; systemic

3.9

24.2

101

262

H52.1

ICD-10 Finland

Myopia

2.9

24.0

146

506

R01AD09

ATC

mometasone; nasal

1.4

23.9

1806

14571

R11

ICD-10 Finland

Nausea and vomiting

1.9

23.7

347

1858

R60.0

ICD-10 Finland

Localized oedema

1.8

23.7

463

2737

L01

ICPC

Neck symptom/complaint

1.7

23.7

552

3442

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.6

23.4

108

306

N86

ICPC

Multiple sclerosis

7.3

23.4

CAC10

NOMESCO Finland

Reconstruction of orbital wall using bone graft or plate

14.5

23.4

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

23.3

730

4916

H50.6

ICD-10 Finland

Mechanical strabismus

33.5

23.3

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

23.2

877

6174

A11

ICPC

Chest pain NOS

2.0

23.1

326

1720

R52.2

ICD-10 Finland

Other chronic pain

2.7

23.0

165

632

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

22.9

2174

18176

SPAT1301

SPAT

No procedures

1.4

22.9

1350

10397

F29

ICPC

Eye symptom/complaint other

1.9

22.9

338

1816

164

Kela drug reimbursment

Fingolimod

13.0

22.9

R4120

NOMESCO Finland

Occupational therapy

2.1

22.9

278

1385

R50.9

ICD-10 Finland

Fever, unspecified

1.6

22.8

576

3672

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

22.8

856

6014

W19

ICD-10 Finland

Unspecified fall

1.8

22.7

397

2263

G47.3

ICD-10 Finland

Sleep apnoea

1.5

22.7

866

6107

D01

ICPC

Abdominal pain/cramps general

1.8

22.7

430

2518

ZXA00

NOMESCO Finland

Right side

1.4

22.5

1109

8250

H51.2

ICD-10 Finland

Internuclear ophthalmoplegia

45.2

22.3

J01EA01

ATC

trimethoprim; systemic

1.5

22.3

1031

7571

A01

ICPC

Pain general/multiple sites

1.9

22.2

319

1698

P76

ICPC

Depressive disorder

2.1

22.1

247

1186

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.5

22.0

177

724

H52.2

ICD-10 Finland

Astigmatism

4.0

22.0

230

H50.4

ICD-10 Finland

Other and unspecified heterotropia

35.2

22.0

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

6.1

22.0

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.5

21.9

104

302

GEC24

NOMESCO Finland

Thoracoscopic thymectomy

38.8

21.7

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.4

21.6

184

777

T90.5

ICD-10 Finland

Sequelae of intracranial injury

4.9

21.5

147

J01CA04

ATC

amoxicillin; systemic

1.4

21.5

3496

31723

SPAT1240

SPAT

Therapeutic discussion

1.8

21.5

416

2450

R05

ICPC

Cough

1.5

21.4

893

6413

A02BC03

ATC

lansoprazole; oral

1.4

21.3

1189

9040

H05.2

ICD-10 Finland

Exophthalmic conditions

10.6

21.3

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

21.3

836

5921

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

21.3

795

5570

R06AE07

ATC

cetirizine; oral

1.4

21.2

1763

14363

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

21.1

1949

16145

J01AA02

ATC

doxycycline; systemic

1.4

21.1

3337

30081

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.9

21.0

327

1791

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

21.0

387

2243

H062, E050

ICD-10 Finland

16.6

20.9

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.7

20.8

149

572

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.9

20.7

334

1852

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

20.6

969

7119

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

20.5

392

2297

A06AD11

ATC

lactulose; oral

1.6

20.5

583

3826

D11

ICPC

Diarrhoea

1.7

20.5

429

2587

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

20.5

332

1845

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

20.4

2632

22909

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

20.3

1388

10922

XKD00

NOMESCO Finland

Uroflowmetry

1.6

20.3

644

4341

G04BD12

ATC

mirabegron; oral

1.7

20.3

410

2446

N30.0

ICD-10 Finland

Acute cystitis

1.6

20.0

557

3636

353

Kela drug reimbursment

Cladribine and fingolimod

13.7

20.0

L04AA27

ATC

fingolimod; oral

13.7

20.0

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.2

20.0

104

325

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

5.4

19.7

110

J01DA01

ATC

[U] cefalexin; systemic

1.3

19.6

2622

22877

M54.1

ICD-10 Finland

Radiculopathy

2.4

19.6

168

712

N06AB06

ATC

sertraline; oral

1.7

19.5

428

2618

J01FA10

ATC

azithromycin; systemic

1.3

19.4

2342

20112

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.9

19.4

207

D06

ICPC

Abdominal pain localized other

1.8

19.4

321

1796

XF404

NOMESCO Finland

Ambulatory ECG

1.7

19.4

383

2269

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

19.3

441

2725

C09AA05

ATC

ramipril; oral

1.4

19.3

988

7374

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

19.3

301

1650

L12

ICPC

Hand/finger symptom/complaint

1.6

19.2

560

3698

PA6AD

NOMESCO Finland

CT of neck arteries

4.3

19.0

163

H26.4

ICD-10 Finland

After-cataract

1.8

19.0

355

2065

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

18.8

697

4865

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

18.8

184

833

M01AB05

ATC

diclofenac; systemic, rectal

1.3

18.7

2757

24314

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.7

18.7

229

EBA00

NOMESCO Finland

Extraction of tooth

1.4

18.7

1305

10277

P01AB01

ATC

metronidazole; oral, rectal

1.3

18.7

1560

12646

L04AA31

ATC

teriflunomide; oral

13.4

18.7

H02AB04

ATC

methylprednisolone; systemic

1.6

18.6

585

3930

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

18.6

258

1354

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

18.6

427

2642

2AB04

NOMESCO Finland

12.3

18.5

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.1

18.5

182

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

18.5

405

2473

L04AX01

ATC

azathioprine; systemic

2.2

18.4

192

894

L08

ICPC

Shoulder symptom/complaint

1.5

18.4

735

5208

R07.3

ICD-10 Finland

Other chest pain

1.7

18.3

377

2260

H50.59

ICD-10 Finland

Heterophor UNS

30.1

18.3

ZX120

NOMESCO Finland

Intravenous

1.7

18.3

385

2323

183

Kela drug reimbursment

Lamotrigin and topiramate

4.8

18.2

125

M01AE02

ATC

naproxen; oral, rectal

1.3

18.2

2311

19915

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

21.8

18.1

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

18.1

919

6834

R52.9

ICD-10 Finland

Pain, unspecified

1.8

18.1

337

1959

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

18.1

921

6854

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

18.0

495

3214

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.3

18.0

154

WX892

NOMESCO Finland

Monitored bed care

1.8

17.9

318

1821

N05AH03

ATC

olanzapine; systemic

2.0

17.9

238

1227

N03AX14

ATC

levetiracetam; systemic

2.7

17.9

122

455

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

17.8

329

1906

A98

ICPC

Health maint/preventive medicine

1.6

17.8

4371

41770

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

17.8

427

2676

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

17.7

550

3679

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.2

17.7

182

843

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

17.7

684

4815

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

17.6

521

3444

N29

ICPC

Neurological sympt/complt other

3.1

17.6

322

N18

ICPC

Paralysis/weakness

3.1

17.6

311

KMAK

NOMESCO Finland

1.3

17.6

2077

17682

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

17.6

1524

12399

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

17.5

887

6585

SPAT1229

SPAT

Assessment of need for aid

1.8

17.5

325

1887

J01FA06

ATC

roxithromycin; oral

1.3

17.5

1601

13130

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.4

17.4

151

645

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

17.4

689

4869

SPAT1254

SPAT

Administration of medicine

1.5

17.4

604

4148

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

17.4

895

6668

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.2

17.3

298

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

17.3

2284

19731

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

17.3

472

3060

N99

ICPC

Neurological disease other

4.0

17.2

170

R51.81

ICD-10 Finland

Facial pain NOS

2.9

17.2

106

373

G50.1

ICD-10 Finland

Atypical facial pain

3.3

17.2

262

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

17.2

410

2564

R21

ICPC

Throat symptom/complaint

1.5

17.1

714

5102

WZC30

NOMESCO Finland

Teaching

1.6

17.0

516

3431

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

17.0

145

616

N06AX12

ATC

bupropion; oral

2.0

16.9

218

1111

R35

ICD-10 Finland

Polyuria

1.9

16.9

265

1455

C08CA01

ATC

amlodipine; oral

1.3

16.9

1398

11276

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

16.9

340

2026

K59.0

ICD-10 Finland

Constipation

2.0

16.8

224

1159

N05AX12

ATC

aripiprazole; systemic

2.3

16.8

152

663

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.0

16.8

327

-1

NOMESCO Finland

1.3

16.8

1305

10422

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.2

16.8

278

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

16.8

425

2701

B01AC07

ATC

dipyridamole; systemic

2.2

16.7

180

850

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

16.7

1618

13358

K30

ICD-10 Finland

Functional dyspepsia

1.7

16.7

399

2495

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

16.7

2346

20405

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

16.7

538

3630

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

16.6

311

1810

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

4.3

16.6

143

H02AB09

ATC

hydrocortisone; systemic

2.8

16.6

107

388

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

16.5

1086

8435

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.6

16.5

212

J02AC01

ATC

fluconazole; systemic

1.3

16.4

1501

12275

CA1AD

NOMESCO Finland

Orbita CT

13.4

16.4

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

16.4

1573

12958

N28

ICPC

Limited function/disability (N)

3.4

16.4

234

S80.0

ICD-10 Finland

Contusion of knee

1.9

16.4

260

1431

G45.3

ICD-10 Finland

Amaurosis fugax

3.4

16.4

229

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

16.4

194

958

C08DA01

ATC

verapamil; systemic

2.1

16.2

175

831

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.2

16.2

157

711

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

16.2

264

1471

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.8

16.1

181

B01AB05

ATC

enoxaparin; parenteral

1.4

16.1

1199

9500

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

16.1

296

1714

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

16.1

840

6264

G04CA02

ATC

tamsulosin; oral

1.4

16.1

868

6512

SPAT1050

SPAT

Extensive neurological examination

2.8

16.0

107

394

WX140

NOMESCO Finland

Parabulbar anesthesy

2.1

16.0

182

881

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.6

16.0

117

458

M54.3

ICD-10 Finland

Sciatica

1.9

16.0

235

1259

B01AA03

ATC

warfarin; systemic

1.4

16.0

778

5725

K04.0

ICD-10 Finland

Pulpitis

1.7

16.0

348

2122

H01

ICPC

Ear pain/earache

1.6

15.9

398

2520

H47.2

ICD-10 Finland

Optic atrophy

13.6

15.9

R01AD08

ATC

fluticasone; nasal

1.4

15.9

1090

8517

SPAT1312

SPAT

General health counselling

1.3

15.9

1295

10399

H25.0

ICD-10 Finland

Senile incipient cataract

1.9

15.9

238

1284

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.9

15.9

164

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

4.2

15.8

145

D02

ICPC

Abdominal pain epigastric

1.9

15.8

224

1186

U02

ICPC

Urinary frequency/urgency

1.6

15.8

492

3291

P03

ICPC

Feeling depressed

1.7

15.8

326

1954

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

4.9

15.8

105

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

15.7

114

443

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.3

15.7

237

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.3

15.7

142

620

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

15.7

209

1082

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

3.0

15.6

315

G43.3

ICD-10 Finland

Complicated migraine

3.5

15.6

207

X58

ICD-10 Finland

Exposure to other specified factors

1.5

15.6

517

3512

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.0

15.5

289

K07.60

ICD-10 Finland

Snapping jaw

2.0

15.5

188

938

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

15.5

404

2586

J01MA12

ATC

levofloxacin; systemic

1.4

15.5

723

5275

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

15.4

1251

10029

C10AA07

ATC

rosuvastatin; oral

1.4

15.4

912

6947

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

15.4

642

4577

N05CF02

ATC

zolpidem; oral

1.5

15.4

667

4797

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

3.6

15.4

189

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.2

15.3

258

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

15.3

904

6882

L02

ICPC

Back symptom/complaint

1.7

15.3

333

2028

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

15.2

398

2553

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

15.2

491

3316

S06.3

ICD-10 Finland

Focal brain injury

3.5

15.1

202

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

4.6

15.1

115

SPAT1216

SPAT

Assessment of functional ability

1.5

15.0

598

4225

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

15.0

281

1639

R33

ICD-10 Finland

Retention of urine

1.7

14.9

301

1794

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

14.9

529

3649

K90

ICPC

Stroke/cerebrovascular accident

2.4

14.9

125

527

J05AB01

ATC

aciclovir; systemic

1.4

14.9

790

5900

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.2

14.9

148

679

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

14.9

561

3919

N06AX26

ATC

vortioxetine; oral

2.0

14.8

202

1056

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

14.8

421

2756

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

14.8

318

1931

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

14.8

139

621

P06

ICPC

Sleep disturbance

1.6

14.7

362

2282

SPAT1097

SPAT

Recording of ECG

1.5

14.7

598

4240

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

14.7

573

4028

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

3.4

14.7

212

CAC30

NOMESCO Finland

Decompression of orbit to sinuses

25.1

14.7

SPAT1260

SPAT

Consultation of another employee

1.4

14.7

716

5265

G44.0

ICD-10 Finland

Cluster headache syndrome

4.0

14.6

147

C01DA14

ATC

isosorbide mononitrate; oral

1.5

14.6

574

4045

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

14.6

666

4837

R1250

NOMESCO Finland

Evaluation of functional capability

2.7

14.5

364

P20

ICPC

Memory disturbance

1.6

14.5

442

2940

N07CA01

ATC

betahistine; oral

1.7

14.5

290

1726

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

14.4

597

4250

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.8

14.4

337

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

7.5

14.4

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

14.3

287

1707

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

5.3

14.3

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

14.3

1001

7830

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

4.4

14.3

117

G91.1

ICD-10 Finland

Obstructive hydrocephalus

7.8

14.3

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.6

14.2

342

2145

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

14.2

314

1924

S22.3

ICD-10 Finland

Fracture of rib

1.8

14.1

248

1415

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

14.1

354

2245

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.5

14.1

458

3095

SPAT1255

SPAT

Intravenous administration of medicine

1.7

14.0

272

1599

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

14.0

339

2128

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.6

14.0

381

2463

H50.50

ICD-10 Finland

Alternating hyperphoria

14.4

14.0

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.6

14.0

178

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

14.0

426

2831

SPAT1153

SPAT

Removal of sutures

1.3

14.0

1269

10316

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.4

14.0

199

M79.7

ICD-10 Finland

Fibromyalgia

2.3

14.0

128

564

Z00.0

ICD-10 Finland

General medical examination

1.4

14.0

708

5241

S29

ICPC

Skin symptom/complaint other

1.4

13.9

627

4535

XCH00

NOMESCO Finland

Eye pressure measurement

2.1

13.9

160

780

N05CD07

ATC

temazepam; oral

1.5

13.9

475

3245

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.6

13.9

336

2107

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.4

13.9

121

519

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

13.9

359

2293

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

3.1

13.8

239

R25.1

ICD-10 Finland

Tremor, unspecified

2.4

13.8

121

522

D09

ICPC

Nausea

2.1

13.8

161

791

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

13.7

448

3026

R4150

NOMESCO Finland

Neuropsychological rehabilitation

5.2

13.7

S00.0

ICD-10 Finland

Superficial injury of scalp

2.7

13.7

356

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

13.7

362

2328

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.9

13.7

296

M48.0

ICD-10 Finland

Spinal stenosis

1.5

13.6

457

3111

WX290

NOMESCO Finland

Other blockade of nerve

1.3

13.6

1667

14106

H54.7

ICD-10 Finland

Unspecified visual loss

6.9

13.6

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

6.9

13.6

H51.9

ICD-10 Finland

Disorder of binocular movement, unspecified

75.3

13.6

N05AA02

ATC

levomepromazine; systemic

2.0

13.6

166

830

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.6

13.5

377

P29

ICPC

Psychological sympt/compl other

1.9

13.5

209

1144

4AA23

NOMESCO Finland

34.1

13.5

L04

ICPC

Chest symptom/complaint

1.8

13.5

222

1239

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

13.5

284

1713

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.9

13.4

272

R03BA05

ATC

fluticasone; inhalant

1.4

13.4

682

5048

N05AX08

ATC

risperidone; systemic

1.7

13.4

287

1743

L15

ICPC

Knee symptom/complaint

1.4

13.4

794

6036

A03

ICPC

Fever

1.4

13.3

576

4133

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

13.3

186

982

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

13.3

243

1406

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

13.3

203

1106

P01

ICPC

Feeling anxious/nervous/tense

1.6

13.2

345

2210

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

13.2

305

1890

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

13.2

363

2354

R03DC03

ATC

montelukast; oral

1.4

13.2

580

4176

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

7.2

13.2

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

13.1

271

1628

N04BB01

ATC

amantadine; oral

3.1

13.1

237

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

13.1

935

7324

S01.0

ICD-10 Finland

Open wound of scalp

1.7

13.1

286

1746

R74

ICPC

Upper respiratory infection acute

1.3

13.1

1013

8035

D07AC01

ATC

betamethasone; topical

1.3

13.1

1314

10817

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

13.1

182

959

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.6

13.0

359

Z01.2

ICD-10 Finland

Dental examination

1.3

13.0

1559

13133

XQ800

NOMESCO Finland

Prick test

1.7

13.0

276

1670

R32

ICD-10 Finland

Unspecified urinary incontinence

2.4

12.9

110

469

I63.8

ICD-10 Finland

Other cerebral infarction

4.4

12.9

106

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.1

12.9

143

687

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.7

12.9

249

1465

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

12.9

161

815

SPAT1262

SPAT

Handing over of treatment supplies

1.4

12.8

700

5244

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

12.8

213

1197

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

12.8

247

1454

S05.1

ICD-10 Finland

Contusion of eyeball and orbital tissues

3.2

12.8

214

WX402

NOMESCO Finland

General anaesthesia

1.4

12.7

620

4553

R27.0

ICD-10 Finland

Ataxia, unspecified

6.3

12.7

XF402

NOMESCO Finland

ECG with work load test

1.5

12.7

423

2874

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

4.3

12.7

108

R00.2

ICD-10 Finland

Palpitations

1.7

12.6

257

1535

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

12.6

723

5461

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

12.6

732

5543

SPAT1310

SPAT

Counselling related to known health issue

1.3

12.6

1251

10275

A29

ICPC

General symptom/complaint other

1.5

12.5

414

2806

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

3.8

12.5

134

BAA60

NOMESCO Finland

Total thyroidectomy

2.5

12.5

402

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.6

12.4

308

1945

L14

ICPC

Leg/thigh symptom/complaint

1.7

12.4

277

1699

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

12.4

198

1097

H81.3

ICD-10 Finland

Other peripheral vertigo

2.4

12.4

106

453

104

Kela drug reimbursment

Thyroid insufficiency

1.7

12.4

270

1648

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

12.3

870

6793

D03

ICPC

Heartburn

2.2

12.2

117

529

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

12.2

165

862

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

12.1

220

1272

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.2

12.1

126

592

G72.9

ICD-10 Finland

Myopathy, unspecified

4.0

12.1

118

N06AX03

ATC

mianserin; oral

1.8

12.0

189

1041

R31

ICD-10 Finland

Unspecified haematuria

1.5

12.0

368

2450

J01FA09

ATC

clarithromycin; systemic

1.3

12.0

1182

9683

R15

ICD-10 Finland

Faecal incontinence

2.4

12.0

410

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.1

12.0

135

657

XKC03

NOMESCO Finland

Water cystometry

2.2

12.0

125

588

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

12.0

286

1791

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

12.0

202

1142

R03BA01

ATC

beclometasone; inhalant

1.4

11.9

521

3743

J01CA08

ATC

pivmecillinam; oral

1.3

11.9

1463

12327

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

11.9

392

2655

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

11.9

374

2504

S20.2

ICD-10 Finland

Contusion of thorax

1.9

11.9

176

948

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

11.9

174

934

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.9

11.9

125

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

11.9

245

1470

A08

ICPC

Swelling

1.9

11.8

166

879

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

7.9

11.8

W17

ICD-10 Finland

Other fall from one level to another

1.9

11.8

163

858

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.6

11.8

279

1745

N05BA09

ATC

clobazam; oral

5.8

11.7

L86

ICPC

Back syndrome with radiating pain

1.8

11.7

216

1254

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

11.7

641

4798

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

11.7

336

2202

C10AX09

ATC

ezetimibe; oral

1.5

11.7

388

2634

N06BA07

ATC

modafinil; oral

7.3

11.7

R03BA02

ATC

budesonide; inhalant

1.4

11.7

640

4793

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.5

11.6

378

R01AD01

ATC

beclometasone; nasal

1.4

11.6

551

4021

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

11.6

170

914

CAC44

NOMESCO Finland

Combined decompression of orbit

65.1

11.6

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.2

11.6

191

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

11.6

232

1383

H93.1

ICD-10 Finland

Tinnitus

1.7

11.5

239

1439

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

3.3

11.5

170

N30

ICD-10 Finland

Cystitis

1.6

11.5

265

1643

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.2

11.5

181

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

11.4

590

4371

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.6

11.4

324

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.0

11.4

210

K04.08

ICD-10 Finland

Other specified pulpit

1.7

11.4

225

1337

C01CA24

ATC

epinephrine; parenteral

1.7

11.4

218

1283

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.5

11.3

344

2284

H52.0

ICD-10 Finland

Hypermetropia

2.8

11.3

249

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

11.3

282

1788

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

11.3

1135

9316

H51.8

ICD-10 Finland

Other specified disorders of binocular movement

35.1

11.3

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

4.3

11.2

S09.9

ICD-10 Finland

Unspecified injury of head

3.2

11.2

185

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

11.2

724

5572

RS221

NOMESCO Finland

2.8

11.1

253

R03BA08

ATC

ciclesonide; inhalant

1.6

11.1

283

1802

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.6

11.1

277

1757

SPAT1325

SPAT

Vaccination

1.3

11.0

1358

11423

N07XX09

ATC

[U] dimethyl fumarate; oral

8.6

11.0

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

11.0

2817

25725

G70.9

ICD-10 Finland

Myoneural disorder, unspecified

13.9

10.9

H29

ICPC

Ear symptom/complaint other

1.5

10.9

363

2461

R52.1

ICD-10 Finland

Chronic intractable pain

3.8

10.9

120

H49.9

ICD-10 Finland

Paralytic strabismus, unspecified

43.4

10.9

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

10.9

697

5353

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

10.9

268

1690

D10

ICPC

Vomiting

1.8

10.8

181

1022

P74

ICPC

Anxiety disorder/anxiety state

2.0

10.8

126

624

M54.2

ICD-10 Finland

Cervicalgia

1.6

10.8

246

1522

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

4.6

10.7

A02BA02

ATC

ranitidine; systemic

1.3

10.7

732

5677

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.7

10.7

229

1390

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

10.7

385

2660

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

10.7

285

1834

L16

ICPC

Ankle symptom/complaint

1.5

10.7

366

2501

R03AC03

ATC

terbutaline; inhalant

1.4

10.7

507

3698

T74.1

ICD-10 Finland

Physical abuse

2.7

10.7

255

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

10.7

446

3178

KH1AD

NOMESCO Finland

CT of urinary organs

2.0

10.7

125

620

WX872

NOMESCO Finland

Intensive care

1.8

10.6

195

1130

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.5

10.6

426

3010

E0000UV

ATC

1.2

10.6

1501

12823

C07AB02

ATC

metoprolol; systemic

1.3

10.6

772

6044

R05

ICD-10 Finland

Cough

1.3

10.6

695

5355

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.8

10.6

169

939

T90

ICPC

Diabetes non-insulin dependent

1.3

10.5

850

6758

J05AB11

ATC

valaciclovir; oral

1.4

10.5

474

3425

R06.5

ICD-10 Finland

Mouth breathing

1.5

10.5

314

2081

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

10.5

704

5445

M01AX17

ATC

nimesulide; oral

1.3

10.5

906

7277

F34.1

ICD-10 Finland

Dysthymia

2.0

10.4

123

610

A99

ICPC

Disease/condition unspecnature/site

1.6

10.4

287

1864

XCW11

NOMESCO Finland

Assessment of strabismus

110.2

10.4

S06.2

ICD-10 Finland

Diffuse brain injury

3.4

10.4

146

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

10.4

226

1380

C09CA06

ATC

candesartan; oral

1.3

10.4

783

6165

L05

ICPC

Flank/axilla symptom/complaint

1.7

10.4

193

1126

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

10.3

1010

8238

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

10.3

667

5131

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

10.3

364

2504

UDM02

NOMESCO Finland

Sinoscopy

2.3

10.3

392

WZA90

NOMESCO Finland

Other doctors statement

1.3

10.3

848

6759

L19

ICPC

Muscle symptom/complaint NOS

2.3

10.3

404

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

10.3

354

L11

ICPC

Wrist symptom/complaint

1.6

10.3

276

1783

N88

ICPC

Epilepsy

4.6

10.3

R5599

NOMESCO Finland

Other rehabilitation service

2.2

10.2

102

471

G54.0

ICD-10 Finland

Brachial plexus disorders

2.3

10.2

387

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

10.2

136

708

N02CC03

ATC

zolmitriptan; nasal, oral

1.8

10.2

175

996

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

10.2

142

751

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

2.8

10.2

232

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.6

10.2

232

1438

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

10.1

1637

14176

J01DC02

ATC

cefuroxime; systemic

1.7

10.1

208

1247

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

10.1

118

583

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

10.1

127

647

R07.0

ICD-10 Finland

Pain in throat

1.7

10.1

201

1198

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

5.4

10.1

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

10.1

790

6250

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.4

10.1

344

G44.8

ICD-10 Finland

Other specified headache syndromes

3.3

10.1

150

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

10.1

526

3903

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

10.1

709

5525

C10AC01

ATC

colestyramine; oral

2.1

10.0

104

490

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

10.0

129

664

H02.3

ICD-10 Finland

Blepharochalasis

1.6

10.0

229

1419

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.3

10.0

375

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.7

10.0

235

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

10.0

422

3011

U01

ICPC

Dysuria/painful urination

1.6

10.0

254

1616

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

10.0

1656

14379

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

10.0

303

2016

WX704

NOMESCO Finland

Intubation

1.6

10.0

260

1665

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

4.7

9.9

N02CC04

ATC

rizatriptan; oral

1.7

9.9

187

1097

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

9.9

216

1321

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

9.9

115

570

A10AE04

ATC

insulin glargine; parenteral

1.5

9.9

333

2269

D07AC13

ATC

mometasone; topical

1.3

9.9

1074

8878

N06AA10

ATC

nortriptyline; systemic

2.4

9.9

333

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.9

9.9

101

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.5

9.9

360

2494

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

9.8

367

2552

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

9.8

474

3467

SPAT1234

SPAT

Support of social functional capacity

1.7

9.8

190

1123

R1260

NOMESCO Finland

Evaluation of communicative skills

2.6

9.8

273

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

9.8

277

1812

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

9.8

137

726

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

20.0

9.8

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

9.8

682

5303

K08.3

ICD-10 Finland

Retained dental root

1.6

9.8

244

1548

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

9.8

339

2326

J46

ICD-10 Finland

Status asthmaticus

2.1

9.7

106

508

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.9

9.7

133

701

R01AD12

ATC

fluticasone furoate; nasal

1.3

9.7

1044

8618

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.5

9.7

123

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

9.7

1033

8518

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

9.6

172

990

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

9.6

864

6964

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.9

9.6

132

696

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

9.6

200

1207

H43.3

ICD-10 Finland

Other vitreous opacities

3.0

9.6

187

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

9.6

226

1412

H81.4

ICD-10 Finland

Vertigo of central origin

4.0

9.6

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

3.3

9.6

140

A07AA02

ATC

nystatin; oral

1.6

9.6

231

1454

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

9.6

201

1216

G40

ICD-10 Finland

Epilepsy

3.6

9.6

114

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

9.5

268

1753

SPAT1283

SPAT

Restricted health certificate

1.4

9.5

567

4300

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

9.5

493

3651

U07

ICPC

Urine symptom/complaint other

1.7

9.5

209

1284

J01MA06

ATC

norfloxacin; oral

1.4

9.5

486

3593

TKC22

NOMESCO Finland

Catheterisation instruction

2.2

9.5

409

SPAT1104

SPAT

Monitoring of emergency patient

1.6

9.5

247

1582

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

9.5

220

1369

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

9.5

152

846

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

4.8

9.4

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.9

9.4

126

658

J45

ICD-10 Finland

Asthma

1.5

9.4

339

2341

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.9

9.4

132

701

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.1

9.4

F44.5

ICD-10 Finland

Dissociative convulsions

30.1

9.4

U05

ICPC

Urination problems other

1.8

9.4

168

969

PA7CC

NOMESCO Finland

Very extensive angiography of arteries of neck and brain

17.5

9.4

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

2.8

9.4

198

H02

ICPC

Hearing complaint

1.4

9.4

430

3117

AA3AD

NOMESCO Finland

CT of face

4.3

9.4

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

9.4

649

5039

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

9.4

284

1888

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

12.3

9.3

R04.0

ICD-10 Finland

Epistaxis

1.6

9.3

249

1608

R52.0

ICD-10 Finland

Acute pain

2.0

9.3

110

548

R4130

NOMESCO Finland

Speech therapy

2.3

9.3

354

N05BA12

ATC

alprazolam; oral

1.5

9.3

360

2524

N02CC06

ATC

eletriptan; oral

2.0

9.3

108

536

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.3

9.2

348

N89

ICPC

Migraine

2.1

9.2

455

M01AH05

ATC

etoricoxib; oral

1.2

9.2

2276

20531

H53

ICD-10 Finland

Visual disturbances

4.1

9.2

K89

ICPC

Transient cerebral ischaemia

3.3

9.2

139

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

9.2

255

1662

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.7

9.2

234

E23.00

ICD-10 Finland

Panhypopituitarism

5.7

9.2

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.8

9.2

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

9.2

164

945

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

9.2

212

1319

N06AA06

ATC

trimipramine; systemic

2.1

9.2

461

K08.80

ICD-10 Finland

Toothache NOS

1.5

9.2

273

1811

S97

ICPC

Chronic ulcer skin

1.7

9.1

190

1146

N05AN01

ATC

lithium; oral

2.2

9.1

416

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

9.1

958

7875

R12

ICD-10 Finland

Heartburn

1.6

9.1

239

1536

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

9.1

3849

36658

S02.40

ICD-10 Finland

Fracture of malar and maxillary bones, closed

3.1

9.1

151

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

9.1

160

917

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.4

9.1

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.5

9.1

114

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.4

9.1

325

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

2.2

9.1

431

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

9.1

106

527

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

9.0

1186

10012

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.9

9.0

178

J20

ICD-10 Finland

Acute bronchitis

1.5

9.0

324

2235

CEC50

NOMESCO Finland

Advancement of extraocular muscle

36.7

9.0

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.9

9.0

119

621

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.8

9.0

198

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

9.0

231

1479

S21

ICPC

Skin texture symptom/complaint

1.4

9.0

447

3289

M02AA10

ATC

ketoprofen; topical

1.3

9.0

566

4331

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.0

8.9

105

523

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.3

8.9

353

A05

ICPC

Feeling ill

1.6

8.9

203

1259

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

8.9

250

1632

H81.0

ICD-10 Finland

Ménière disease

2.2

8.9

408

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.0

8.9

160

U04

ICPC

Incontinence urine

1.8

8.9

158

913

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

12.5

8.8

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

8.8

278

1864

L29

ICPC

Musculoskeletal sympt/complt other

1.5

8.8

260

1717

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.2

8.8

410

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.5

8.8

272

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

8.8

229

1471

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

8.8

308

2119

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

8.7

144

810

H16.0

ICD-10 Finland

Corneal ulcer

1.8

8.7

155

893

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

8.7

319

2210

101

Kela drug reimbursment

Anterior pituitary hypofunction

4.1

8.7

M01AC06

ATC

meloxicam; systemic, rectal

1.2

8.7

1355

11646

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.7

8.7

181

1095

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

3.2

8.7

140

K04.09

ICD-10 Finland

Pulpit UNS

1.9

8.7

132

722

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.0

8.7

101

501

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

8.7

122

649

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.4

8.7

351

2486

D12

ICPC

Constipation

1.9

8.7

120

637

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.2

8.6

130

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.1

8.6

N06AB05

ATC

paroxetine; oral

1.6

8.6

208

1311

M05BA04

ATC

alendronic acid; oral

1.5

8.5

288

1966

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.9

8.5

168

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

8.5

969

8036

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

8.5

229

1481

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.6

8.5

197

1225

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

3.9

8.5

S01EE01

ATC

latanoprost; ophthalmic

1.6

8.5

205

1289

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

8.5

238

1557

3785A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Paralytic strabismus

27.5

8.5

T89

ICPC

Diabetes insulin dependent

1.9

8.5

128

699

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

8.4

190

1174

N03AB02

ATC

phenytoin; systemic

2.8

8.4

189

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.2

8.4

385

N03AX18

ATC

lacosamide; systemic

4.1

8.4

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.6

8.4

208

1319

L18

ICPC

Muscle pain

1.8

8.4

132

732

R2110

NOMESCO Finland

Giving the first information

1.6

8.4

236

1544

B01AF02

ATC

apixaban; oral

1.4

8.4

339

2395

D33.11

ICD-10 Finland

Brain stem

90.2

8.4

R03BB04

ATC

tiotropium bromide; inhalant

1.4

8.4

343

2431

XA402

NOMESCO Finland

ENMG

2.1

8.4

446

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

4.7

8.4

R06AX27

ATC

desloratadine; oral

1.3

8.3

932

7710

CEC85

NOMESCO Finland

Combined correction of cyclodeviation

+∞

8.3

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.6

8.3

209

PA6AM

NOMESCO Finland

Simple MRI examination of neck vasculature with 3 Tesla magnet

8.5

8.3

R03CA02

ATC

ephedrine; oral

10.7

8.3

G93.2

ICD-10 Finland

Benign intracranial hypertension

10.7

8.3

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.2

8.3

341

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.1

8.3

140

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

5.5

8.3

A10AE05

ATC

insulin detemir; parenteral

1.6

8.2

190

1184

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

8.2

1010

8447

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.7

8.2

204

N06AG02

ATC

moclobemide; oral

1.7

8.2

159

942

PAW37

NOMESCO Finland

Biopsy of temporal artery

3.6

8.2

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.6

8.2

SBB10

NOMESCO Finland

Teeth copy

1.6

8.2

210

1341

A01AB09

ATC

miconazole; local oral

1.5

8.2

315

2206

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

8.2

202

1280

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.3

8.2

315

R06.4

ICD-10 Finland

Hyperventilation

2.5

8.2

258

F31

ICD-10 Finland

Bipolar affective disorder

2.9

8.2

162

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

8.1

189

1180

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.3

8.1

305

D32.06

ICD-10 Finland

Benign tumor of the meninges os petrosum or clivus area

7.5

8.1

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

8.1

187

1163

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

3.9

8.1

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

5.7

8.1

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

8.1

188

1171

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

474

196

26.45

307.65

1.1

4.5

14.5

nmol/l

0.61

111

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2476

12918

2.71

269.60

2.8

2.1

201.1

223.1

u/l

0.14

2383

12081

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1480

6610

2.72

210.16

2.3

2.1

29.5

29.9

1.63

1430

6400

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

449

996

4.83

189.07

1.4

1.3

577.2

528.8

mg/l

0.58

434

945

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

233

272

8.91

184.28

1.2

60.5

40.2

mg/l

1.07

194

224

(3013826) Glucose [Moles/volume] in Serum or Plasma

3655

25606

2.36

178.75

6.5

4.6

6.6

6.7

mmol/l

1.80

3507

23877

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

224

265

8.78

175.25

1.1

346.5

276.4

mg/l

0.62

200

222

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

403

875

4.90

173.84

1.3

3.6

3.8

mmol/l

1.85

381

825

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

398

876

4.83

168.81

1.4

16.8

27.6

e6/l

0.63

317

675

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

397

877

4.81

167.63

1.5

2386.8

5330.2

e6/l

0.30

330

718

(3044290) Cell count panel - Cerebral spinal fluid

375

797

4.99

165.79

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

212

253

8.69

164.65

1.1

—

(4027681)

188

204

9.52

157.15

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

233

348

6.96

148.98

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

248

406

6.36

145.18

1.1

—

4.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

178

202

9.08

143.73

1.1

1.0

1.1

u/l

1.57

103

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3132

21797

2.06

138.73

8.2

6.6

1.2

mmol/l

0.40

2729

18361

(3032080) INR in Blood by Coagulation assay

2667

17694

2.01

132.94

9.9

9.4

1.2

1.3

inr

0.59

766

5097

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2888

19751

2.01

131.52

7.3

5.9

1.2

mmol/l

0.96

2683

17879

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

704

2810

2.73

118.78

2.5

2.4

23.9

22.8

au/ml

0.06

151

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2446

16437

1.90

110.47

4.6

3.6

25.8

82.2

ng/l

1.33

1723

11301

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

642

2575

2.70

106.72

1.4

1.3

41.8

50.6

au/ml

0.29

113

(3024561) Albumin [Mass/volume] in Serum or Plasma

2684

18864

1.85

102.63

5.4

4.8

35.4

g/l

0.00

2520

17495

(3023410) Appearance of Cerebral spinal fluid

202

380

5.49

102.11

1.5

1.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4018

32253

2.00

99.88

5.1

4.0

12.0

12.3

mm/h

0.76

3787

29795

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3055

22651

1.82

95.12

6.9

6.2

11.3

11.5

umol/l

0.41

2888

21478

(3006315) Basophils [#/volume] in Blood

2966

21798

1.81

95.09

8.1

5.8

0.0

e9/l

0.37

2603

18784

(3001604) Monocytes [#/volume] in Blood

2956

21704

1.81

95.06

8.1

5.8

0.6

e9/l

1.10

2596

18704

(3033658) Prothrombin time (PT) actual/Normal

1764

11061

1.89

95.05

5.0

3.9

90.4

89.3

1.05

1729

10784

(42870588) Differential panel, method unspecified - Blood

2203

14810

1.83

94.99

7.5

5.8

—

(3013115) Eosinophils [#/volume] in Blood

3036

22537

1.81

93.42

8.3

6.0

0.2

e9/l

0.06

2695

19759

(3031040) Bacteria [#/volume] in Urine by Automated count

3684

29006

1.87

93.38

6.3

4.4

919.4

1747.0

e6/l

0.90

413

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4111

33618

1.97

91.84

9.2

7.5

79.4

78.2

u/l

0.76

3905

31634

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

13.97

91.23

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

195

403

4.98

88.58

1.4

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

2992

22340

1.77

87.97

8.1

5.8

1.9

e9/l

0.67

2660

19641

(3018418) pH of Serum or Plasma

1961

12973

1.81

87.19

4.4

4.0

7.4

0.02

341

2525

(3022096) Basophils/100 leukocytes in Blood

2710

19778

1.75

85.23

8.3

6.0

0.7

0.01

2578

18420

(3013650) Neutrophils [#/volume] in Blood by Automated count

3275

25260

1.77

84.41

11.5

8.9

4.2

4.1

e9/l

0.25

2922

22019

(3006504) Eosinophils/100 leukocytes in Blood

2766

20371

1.74

83.61

8.2

6.0

2.8

0.04

2632

18948

(3005719) IgG [Mass/volume] in Serum or Plasma

691

3205

2.33

83.10

2.5

2.7

10.1

10.5

g/l

1.86

639

2919

(3037467) Urinalysis macro (dipstick) panel - Urine

3754

30229

1.82

82.47

5.9

4.3

—

(3019069) Monocytes/100 leukocytes in Blood

2771

20495

1.73

81.79

8.5

6.3

8.7

0.84

2642

19155

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1385

8429

1.87

79.31

4.8

3.7

324.6

536.6

ng/l

0.89

1040

6608

(3018010) Neutrophils/100 leukocytes in Blood

2779

20753

1.71

77.57

8.1

5.9

57.9

57.5

1.29

2648

19372

(3002030) Lymphocytes/100 leukocytes in Blood

2811

21058

1.71

77.54

8.4

6.1

27.0

27.7

2.84

2669

19569

(3023368) Bacteria identified in Blood by Culture

1802

11970

1.76

76.65

5.3

4.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4006

33315

1.81

74.03

5.1

3.9

14.8

pmol/l

0.08

3695

30258

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2453

17920

1.68

72.59

2.2

2.0

94.5

95.0

pmol/l

0.20

1303

9338

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4577

39909

2.04

70.65

6.1

4.7

1.9

2.1

mu/l

2.18

4272

36513

(3026008) Bacteria identified in Urine by Culture

1926

13280

1.70

70.16

3.9

3.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4881

43718

2.38

68.79

22.0

14.2

22.2

24.1

mg/l

3.92

4153

34738

(3018095) Leukocytes [#/volume] in Urine

2184

15632

1.67

68.69

5.0

3.7

91.3

105.9

e6/l

0.22

1623

11050

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1475

9491

1.77

68.56

2.1

1.7

1.1

1.2

mg/l

0.91

1140

7267

(36304419) Bacteria [Presence] in Urine

1764

11946

1.71

68.23

4.0

3.1

—

(3002582) Erythrocytes [#/volume] in Urine

1929

13420

1.69

67.24

4.3

3.2

75.5

77.3

e6/l

0.02

1529

10287

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

428

1759

2.56

66.60

1.8

1.9

37.9

38.8

u/l

0.41

393

1557

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1172

7107

1.83

66.17

2.1

1.8

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

149

314

4.85

66.10

1.2

1.3

1.9

2.1

mmol/l

2.12

136

298

(3030467) Casts [#/volume] in Urine by Automated count

1794

12295

1.69

65.85

4.1

3.1

0.4

e6/l

0.36

1400

9248

(3019550) Sodium [Moles/volume] in Serum or Plasma

4959

44867

2.50

65.79

24.8

16.3

139.6

mmol/l

0.07

4893

43716

(3023103) Potassium [Moles/volume] in Serum or Plasma

4964

44990

2.50

64.56

24.9

16.5

4.0

mmol/l

2.59

4884

43753

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1942

13674

1.66

63.78

3.3

2.5

53.4

58.5

u/l

7.30

1784

12605

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1157

7086

1.81

62.80

3.8

3.4

0.8

mmol/l

0.46

1085

6605

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1800

12468

1.67

62.75

3.3

3.0

1200.1

1469.1

ng/l

2.06

1555

10725

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

888

5019

1.92

62.09

8.1

7.1

5.1

kpa

0.42

842

4785

(3027801) Oxygen [Partial pressure] in Arterial blood

887

5019

1.92

61.78

8.1

7.1

12.3

kpa

0.01

845

4784

(3003396) Base excess in Arterial blood by calculation

885

5004

1.92

61.78

8.1

7.1

1.2

1.1

mmol/l

0.38

706

3872

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1191

7457

1.77

59.57

3.5

2.7

1.2

1.1

e6/l

0.30

690

4209

(3015377) Calcium [Moles/volume] in Serum or Plasma

2031

14684

1.62

58.71

3.3

3.4

2.3

2.4

mmol/l

2.41

1740

12775

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

13.63

57.89

3.4

2.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

854

4877

1.89

57.48

1.9

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

1411

9373

1.69

56.54

3.2

2.6

5.6

5.5

e6/l

0.06

1265

8186

(3037522) Nuclear Ab [Titer] in Serum

959

5738

1.82

55.46

1.4

1.3

425.5

546.0

titre

1.48

199

1196

(3026782) Osmolality of Urine

1330

8742

1.69

55.24

3.3

2.8

554.5

547.7

mosm/kgh2o

0.50

1160

7447

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

153

380

4.12

55.15

1.6

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

282

1034

2.82

54.81

2.7

1.9

4.1

4.7

iu/l

0.45

126

370

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

843

4892

1.86

53.66

2.0

1.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

706

3892

1.94

52.54

2.4

2.1

356.5

373.5

nmol/l

1.43

653

3559

(3016502) Oxygen saturation in Arterial blood

783

4487

1.87

51.71

8.5

7.5

95.7

0.08

756

4321

(3021960) Folate [Moles/volume] in Serum or Plasma

1483

10178

1.63

51.46

1.6

1.5

19.5

20.3

nmol/l

1.25

1291

8704

(3019309) Folate [Moles/volume] in Red Blood Cells

1247

8207

1.68

50.91

1.8

1114.3

1172.0

nmol/l

1.43

992

6209

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1098

6987

1.72

50.81

3.7

2.9

3.7

2.4

e6/l

2.54

594

3775

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1920

14097

1.57

49.74

3.8

3.2

31.7

35.9

u/l

1.63

1826

13356

(3035350) Ketones [Presence] in Urine by Test strip

2696

21413

1.52

48.23

4.6

3.6

0.0

estimate

1.08

512

4000

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

100

197

5.15

48.00

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2315

17862

1.52

47.04

2.6

2.2

76.1

77.5

nmol/l

1.59

2124

16014

(3021601) Nitrite [Presence] in Urine by Test strip

2686

21431

1.51

46.24

6.3

4.9

0.0

estimate

0.80

514

4073

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3404

28552

1.53

46.13

4.1

3.1

53.0

48.7

u/l

1.39

3224

26510

(3009261) Glucose [Presence] in Urine by Test strip

2708

21686

1.51

45.51

4.7

3.7

0.0

estimate

1.04

502

3956

(3002173) Hemoglobin [Mass/volume] in Arterial blood

714

4142

1.84

44.91

9.1

7.9

122.2

121.3

g/l

0.60

691

3989

(3007164) IgA [Mass/volume] in Serum or Plasma

1215

8175

1.63

44.63

1.6

1.5

2.4

2.5

g/l

0.72

741

4966

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

144

5.77

44.61

1.2

1.1

2464.4

247.5

ng/l

1.15

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

11.63

43.81

1.2

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

884

5508

1.73

43.43

8.7

6.7

104.6

104.4

mmol/l

0.35

861

5389

(3003458) Phosphate [Moles/volume] in Serum or Plasma

907

5709

1.71

42.90

6.3

5.9

1.0

mmol/l

0.99

849

5310

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2388

18783

1.49

42.85

3.2

2.8

133.0

128.1

ug/l

0.34

2210

17381

(3022948) Iron [Moles/volume] in Serum or Plasma

1050

6914

1.65

41.68

2.5

12.7

13.0

umol/l

0.52

971

6416

(40758558) Short blood count panel - Blood

1537

11081

1.54

41.47

8.0

6.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

164

518

3.23

41.39

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1543

11166

1.54

40.79

2.5

2.2

3.0

mg/l

0.04

1344

9546

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2564

20589

1.47

40.68

4.8

4.1

—

(3021589) Normoblasts [#/volume] in Blood

2437

19376

1.47

40.67

12.1

9.6

0.0

e9/l

2.11

2036

15816

(3000991) Gas panel - Venous blood

626

3608

1.83

39.94

10.5

8.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

819

5109

1.71

39.77

2.1

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1323

9325

1.56

39.11

1.3

2.0

1.8

u/ml

0.09

348

2449

(3011397) Hemoglobin [Presence] in Urine by Test strip

1415

10144

1.54

38.66

4.7

3.6

—

(3044640) Blood type and Crossmatch panel - Blood

1845

13981

1.49

38.66

2.9

2.4

—

(3012544) pH of Venous blood

698

4204

1.76

38.32

5.0

3.7

7.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

201

4.59

38.20

1.1

—

(3036489) Thrombin time

331

1551

2.21

37.87

2.4

2.1

21.2

21.5

0.27

292

1353

(3002032) Base excess in Venous blood by calculation

676

4048

1.77

37.83

5.0

3.7

1.8

2.0

mmol/l

0.37

551

3284

(3028026) IgM [Mass/volume] in Serum or Plasma

472

2530

1.95

37.59

2.0

1.9

1.3

1.4

g/l

0.42

441

2297

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

557

3158

1.85

37.35

1.8

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

287

1277

2.32

37.16

1.7

1.6

1.2

g/l

0.35

277

1204

(3014111) Lactate [Moles/volume] in Serum or Plasma

641

3806

1.78

36.88

9.2

6.7

1.3

1.4

mmol/l

1.19

618

3665

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

635

3762

1.78

36.81

2.9

2.3

7.7

7.4

ug/l

0.11

554

3293

(3021447) Carbon dioxide [Partial pressure] in Venous blood

672

4059

1.75

36.41

5.0

3.7

5.8

kpa

0.01

647

3936

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

278

1232

2.33

36.33

1.7

1.6

0.2

g/l

0.92

266

1160

(3014148) Varicella zoster virus Ab [Titer] in Serum

148

477

3.16

36.15

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

6.81

36.02

1.2

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

212

4.35

35.75

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

476

2605

1.91

35.57

3.8

3.2

4.4

4.5

pmol/l

0.42

430

2309

(3022217) INR in Platelet poor plasma by Coagulation assay

879

5762

1.63

34.88

26.3

25.0

1.2

1.4

inr

2.10

128

833

(40761511) CBC panel - Blood by Automated count

4877

45438

1.86

34.79

19.8

13.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4384

39737

1.58

34.55

6.7

5.7

40.4

39.8

mmol/mol

3.05

4086

36724

(3004789) Transferrin [Mass/volume] in Serum or Plasma

952

6390

1.60

34.20

2.6

2.4

2.3

g/l

0.47

881

5913

(3020630) Protein [Mass/volume] in Serum or Plasma

608

3652

1.75

33.44

2.2

2.5

66.2

66.3

g/l

0.15

561

3320

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

421

2262

1.94

33.19

10.7

9.1

24.7

24.3

mmol/l

1.74

395

2121

(3009445) Proteinase 3 Ab [Units/volume] in Serum

359

1830

2.03

32.90

1.7

1.5

13.2

16.4

u/ml

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4951

46472

1.91

32.69

14.4

10.3

26.1

26.2

u/l

0.06

4821

44756

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

891

5951

1.60

32.52

2.6

2.5

22.0

22.8

0.93

748

5069

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

303

1459

2.14

32.32

2.9

2.3

256.1

661.1

ug/l

2.07

281

1374

(3044889) 12 lead EKG panel

3498

30462

1.43

32.11

4.5

3.8

—

(3019060) Gas panel - Arterial blood

503

2913

1.80

31.27

5.0

4.9

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

196

4.23

31.19

1.2

1.3

57.0

64.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

638

3956

1.70

31.17

7.5

7.3

8.9

10.0

mmol/l

3.83

605

3778

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1424

10629

1.46

30.65

2.9

2.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4465

40963

1.55

29.90

19.4

13.3

81.6

80.7

ml/min/173m2

1.92

3875

33720

(3024354) Oxygen [Partial pressure] in Venous blood

554

3341

1.73

29.89

4.6

3.1

4.7

4.6

kpa

0.43

531

3229

(3015171) Extractable nuclear Ab [Units/volume] in Serum

322

1640

2.03

29.55

1.2

0.4

1.1

u/ml

1.51

161

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

239

1087

2.25

29.37

1.7

1.9

12.6

11.4

mg/l

0.28

226

1006

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1025

7213

1.52

29.34

1.3

27.9

32.1

iu/ml

0.45

287

2223

(3009466) Valproate [Moles/volume] in Serum or Plasma

157

590

2.71

29.12

5.2

5.0

371.6

356.6

umol/l

0.57

135

517

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1269

9352

1.47

28.88

1.7

28571867.1

28812463.0

pmol/l

0.00

1071

7778

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1110

7994

1.49

28.29

3.0

2.4

2.5

mmol/l

1.77

952

6976

(3008152) Bicarbonate [Moles/volume] in Arterial blood

476

2792

1.77

28.25

7.2

7.0

24.7

24.6

mmol/l

0.30

447

2602

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

450

2597

1.80

28.21

1.9

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

748

4947

1.60

28.13

2.9

2.8

9.0

8.6

umol/l

0.17

648

4292

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

537

3266

1.72

28.04

3.8

92.0

90.9

ng/l

0.08

474

2792

(3004588) Protein electrophoresis panel - Serum or Plasma

502

3000

1.74

27.91

2.1

2.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4553

42108

1.56

27.72

5.1

4.5

6.0

5.9

mmol/l

0.96

4214

38320

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

751

4991

1.59

27.63

4.0

4.1

240.4

243.0

u/l

0.18

708

4702

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

634

4049

1.64

27.47

2.8

2.4

33.1

50.5

u/l

0.81

541

3456

(3042936) Bacteria identified in Isolate by Culture

891

6180

1.53

27.06

2.4

2.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

415

2375

1.81

26.72

10.4

9.7

—

(3009508) Creatinine [Moles/volume] in Urine

1733

13682

1.40

26.49

3.6

3.2

7.4

7.6

mmol/l

0.62

1455

11489

(3017143) Hepatitis C virus Ab [Presence] in Serum

717

4806

1.57

25.27

1.7

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

439

2604

1.75

24.98

1.6

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

240

1176

2.09

24.45

3.1

2.5

182.6

191.6

0.83

226

1117

(46235355) HIV 1 and 2 tests - Meaningful Use set

1016

7386

1.46

24.24

2.0

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

125

4.60

24.23

1.1

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

370

2114

1.81

23.92

4.9

3.9

24.2

mmol/l

0.02

337

1906

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

258

1310

2.02

23.86

1.7

1.6

37.2

8.0

iu/ml

0.36

274

(3002385) Erythrocyte distribution width [Ratio]

3984

36204

1.40

23.73

26.3

17.2

13.8

13.7

2.33

3937

35407

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

270

3.30

23.41

1.9

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

232

1142

2.08

23.36

1.5

1.4

15.8

13.7

iu/ml

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

274

1433

1.96

23.30

1.6

145.5

344.3

titre

1.23

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

255

1301

2.01

23.27

2.7

2.3

95.1

91.6

1.65

242

1227

(3007461) Platelets [#/volume] in Blood

5074

48578

1.92

23.18

32.2

20.9

250.2

250.4

e9/l

0.05

4997

47320

(3035941) MCH [Entitic mass]

5075

48598

1.92

23.06

32.0

20.8

30.3

0.89

5033

47878

(3024731) MCV [Entitic volume]

5075

48600

1.92

23.03

32.0

20.8

91.1

91.0

0.06

5034

47879

(3010813) Leukocytes [#/volume] in Blood

5076

48617

1.92

22.96

32.2

20.9

6.9

6.8

e9/l

3.61

4982

47196

(3026361) Erythrocytes [#/volume] in Blood

5075

48606

1.92

22.93

32.2

20.9

4.5

e12/l

3.52

4979

47190

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

154

646

2.43

22.83

1.3

1.2

7.0

3.5

u/ml

0.84

214

(3000963) Hemoglobin [Mass/volume] in Blood

5075

48619

1.91

22.71

32.3

21.0

133.9

135.1

g/l

7.05

5032

47900

(3048689) Calprotectin [Mass/mass] in Stool

738

5110

1.52

22.25

2.3

178.9

141.1

ug/g

0.54

587

4026

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3087

27122

1.33

21.85

3.4

2.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

191

896

2.17

21.79

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

191

896

2.17

21.79

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

258

1356

1.95

21.63

1.8

1.6

420.2

302.8

mu/l

0.49

230

1235

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

4.79

21.47

1.1

—

(3011412) CD3 cells [#/volume] in Blood

110

405

2.75

21.31

2.7

2.4

1.2

1.1

e9/l

0.85

252

(3019150) Specific gravity of Urine by Refractometry

1225

9407

1.39

21.17

5.4

4.0

1.0

kg/l

0.85

178

1413

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

10.04

21.15

1.1

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

713

4967

1.50

20.79

2.5

1.8

0.41

615

4397

(3013512) EKG study

1576

12633

1.35

20.73

4.7

3.9

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

319

1821

1.80

20.66

5.1

5.3

1.7

0.53

300

1705

(3012516) Albumin [Mass/volume] in Urine

1592

12799

1.35

20.49

3.4

3.3

805.2

360.5

mg/l

1.87

1007

8111

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

165

3.79

20.48

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

317

2.94

20.16

2.3

2.1

13.9

0.02

136

(3004119) Hemoglobin [Mass/volume] in Venous blood

425

2648

1.66

20.08

4.8

3.1

130.0

128.9

g/l

0.47

411

2577

(40768797) Stomach Pathology biopsy report

819

5909

1.46

19.95

1.3

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1989

16567

1.32

19.91

5.1

3.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

561

3760

1.55

19.52

3.4

2.9

178.3

204.2

ng/l

0.77

505

3413

(36660697) Celiac disease serology panel - Serum

511

3354

1.58

19.50

1.2

—

(3047181) Lactate [Moles/volume] in Blood

255

1389

1.88

19.21

5.7

6.4

1.2

1.3

mmol/l

0.30

230

1221

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4390

40967

1.41

19.16

4.4

3.9

1.3

mmol/l

0.58

4046

37417

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

708

5002

1.48

19.16

2.0

1.8

1.5

2.06

603

4422

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

143

630

2.30

19.03

1.3

1.2

4.7

4.2

u/ml

0.15

271

(3025941) Bacteria identified in Stool by Culture

388

2394

1.67

19.02

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

310

1801

1.77

18.91

5.2

5.4

0.9

0.03

293

1691

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

260

3.07

18.78

3.1

2.6

0.2

e9/l

0.16

229

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

920

6853

1.41

18.71

1.3

1.2

13.0

12.4

u/ml

0.07

311

2673

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

237

1275

1.90

18.55

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

237

1276

1.90

18.51

2.0

1.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

273

3.00

18.49

3.0

2.6

460.6

528.6

e6/l

0.67

231

(3020682) Albumin/Creatinine [Ratio] in Urine

1645

13481

1.32

18.04

4.1

4.0

9.8

9.4

mg/mmol

0.14

1031

8570

(3000060) B lymphocytes [#/volume] in Blood

100

4.43

17.96

2.6

2.1

1978.4

155.2

e6/l

0.46

(3000494) Fungus identified in Specimen by Culture

707

5054

1.46

17.94

1.6

1.5

—

(40761535) Cells panel - Urine sediment

535

3615

1.53

17.89

4.8

3.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

291

1690

1.76

17.78

2.1

2.2

3.6

3.8

g/l

1.31

194

1212

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

291

1691

1.76

17.74

2.0

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

291

1692

1.76

17.71

2.1

2.2

7.3

7.5

g/l

0.63

203

1265

(3029937) Albumin [Presence] in Urine by Test strip

1444

11643

1.33

17.69

5.4

4.0

0.0

estimate

1.28

506

3918

(40768804) Tissue Pathology biopsy report

2096

17800

1.29

17.48

2.2

2.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

107

4.23

17.36

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

141

643

2.23

17.32

4.6

3.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

402

2578

1.60

16.88

1.4

1.3

327.1

200.2

u/ml

0.88

373

2371

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

1582

1.76

16.81

2.0

2.2

3.1

g/l

0.32

199

1241

(3021879) Hepatitis B virus core Ab [Presence] in Serum

467

3108

1.55

16.70

1.5

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1415

11461

1.32

16.59

3.0

2.7

4324.5

4742.5

umol/l

0.14

1223

9930

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.69

16.56

1.9

2.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

129

3.82

16.49

1.3

1.2

13.2

19.7

—

(3006245) CD3-CD19+ cells/100 cells in Blood

149

3.58

16.24

2.9

2.1

10.0

9.9

0.01

140

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4603

43584

1.41

16.07

5.6

4.8

2.6

2.7

mmol/l

12.63

4290

40079

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

242

1373

1.80

16.02

2.8

3.3

40.2

58.5

mg/l

0.72

200

1105

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

829

6222

1.39

15.91

1.7

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

268

1571

1.74

15.87

2.0

2.2

9.5

10.3

g/l

2.29

217

1329

(3049717) Cytology report of Urine Cyto stain

281

1670

1.72

15.84

2.4

2.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1212

9660

1.33

15.79

6.3

4.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

246

1413

1.78

15.63

2.5

2.1

1870.0

5769.1

u/l

2.79

545

(4306422)

133

619

2.18

15.58

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

179

932

1.95

15.50

2.7

3.0

32.0

35.2

umol/l

0.96

154

787

(3024869) Neuronal Ab [Presence] in Serum

4.95

15.44

1.2

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

586

4155

1.46

15.41

2.4

2.3

0.2

g/l

0.73

534

3877

(4268621)

103

433

2.41

15.32

2.4

2.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

239

1375

1.77

15.11

2.8

3.3

46.1

103.6

mg/l

0.77

199

1105

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

312

2.65

15.02

2.3

2.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

316

1966

1.65

14.99

4.7

2.5

0.7

0.42

307

1885

(3027273) Bicarbonate [Moles/volume] in Venous blood

329

2071

1.63

14.90

4.8

3.3

25.2

25.3

mmol/l

0.18

316

2004

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4488

42425

1.37

14.88

4.9

4.3

1.4

1.5

mmol/l

9.19

4164

39023

(3022145) Colonoscopy Study observation

659

4806

1.42

14.87

1.4

1.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

263

1563

1.72

14.84

4.3

3.9

1.3

1.4

mmol/l

0.81

257

1538

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

107

3.95

14.82

1.0

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

533

3738

1.47

14.81

4.8

4.1

1.0

0.9

0.21

163

1052

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4517

42750

1.37

14.80

5.0

4.3

4.5

4.6

mmol/l

19.29

4222

39544

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

246

1436

1.75

14.79

2.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

235

1355

1.77

14.75

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

278

1680

1.69

14.75

1.1

6.0

1.2

u/ml

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

168

873

1.95

14.65

5.0

5.6

322.0

2370.4

iu/ml

0.58

121

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

232

1337

1.77

14.59

2.7

3.3

5.8

2.2

ratio

0.43

107

(3000570) Elastase.pancreatic [Mass/mass] in Stool

219

1242

1.80

14.54

1.5

1.4

278.8

276.6

ug/g

0.06

129

705

(3023511) Choriogonadotropin [Units/volume] in Urine

142

699

2.06

14.41

1.6

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

207

1158

1.82

14.38

1.2

60.4

42.2

u/ml

—

(3052851) Hemolysis interference index of Serum or Plasma

227

1306

1.77

14.36

3.4

3.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

355

2297

1.58

14.35

2.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

489

3404

1.48

14.09

4.7

3.9

0.5

0.6

0.62

105

761

(3020191) Ethanol [Moles/volume] in Serum or Plasma

347

2.50

14.01

1.7

1.4

1.1

1.2

promille

0.33

266

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

127

606

2.12

14.00

1.1

1.2

123.8

115.2

2.01

116

551

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

420

2839

1.52

13.96

1.2

119.1

142.7

iu/ml

0.66

155

1043

(3043409) Potassium [Moles/volume] in Arterial blood

229

1337

1.74

13.78

4.7

4.1

3.9

mmol/l

0.48

211

1251

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

113

3.74

13.76

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

113

3.74

13.76

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

4.04

13.51

1.1

—

(3039000) Anion gap in Blood

180

987

1.85

13.36

6.6

7.4

10.8

11.2

mmol/l

1.18

165

884

(3018572) Chloride [Moles/volume] in Blood

180

988

1.85

13.32

6.6

7.4

105.6

105.1

mmol/l

0.78

165

885

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.71

13.28

1.9

2.0

21.6

15.9

umol/l

1.14

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

281

2.62

13.12

2.9

2.5

726.1

641.4

e6/l

0.52

117

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

219

1282

1.74

13.07

1.7

—

(3009343) pH of Capillary blood

406

2763

1.51

13.06

3.7

7.4

0.56

353

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

213

1238

1.75

13.04

4.0

2.6

3.6

3.5

g/l

0.57

206

1173

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

410

2801

1.50

12.95

3.7

5.2

kpa

0.08

371

2592

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

331

2.47

12.88

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

228

2.78

12.76

1.1

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

212

2.85

12.71

1.4

1.3

127.1

133.8

nmol/l

0.36

212

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

270

1688

1.63

12.59

2.1

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

284

1799

1.61

12.56

2.1

1.9

1.8

2.3

ug/l

0.28

253

1585

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

106

493

2.17

12.52

1.7

1213.3

1018.9

titre

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

100

455

2.22

12.46

1.2

100.5

95.5

1.10

430

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

933

7381

1.32

12.46

1.7

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

390

2667

1.50

12.26

3.6

1.6

1.9

mmol/l

0.58

283

1968

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.81

12.25

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

498

3573

1.43

12.22

4.9

4.1

0.1

0.2

0.62

144

980

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

257

2.63

12.15

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

213

1266

1.71

12.06

2.2

2.0

0.0

g/l

0.27

196

1161

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

131

671

1.98

11.98

2.4

2.8

794.0

1578.9

u/ml

—

(3035637) Corticotropin [Mass/volume] in Plasma

107

510

2.12

11.89

1.7

1.5

—

(3025159) Blasts/100 leukocytes in Blood

471

3363

1.44

11.86

5.0

4.1

0.1

0.3

1.06

119

819

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

214

1280

1.70

11.85

1.4

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

513

3724

1.42

11.79

2.4

2.6

69.9

69.1

e9/l

0.20

398

2809

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

150

809

1.88

11.77

1.3

1.2

66.7

251.2

titre

—

(21494815) CD4 cells/100 lymphocytes in Specimen

352

2.35

11.74

2.0

2.3

41.3

39.7

0.13

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.75

11.64

1.1

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1361

11391

1.26

11.61

1.8

1.6

1.4

mmol/l

0.96

1158

9546

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

241

1498

1.64

11.52

3.0

0.3

u/ml

1.56

141

875

(3024928) Oxygen saturation in Venous blood

164

916

1.82

11.52

5.5

2.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

131

683

1.94

11.40

1.9

1.6

0.9

0.8

g/l

0.57

520

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.66

11.40

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

187

1093

1.74

11.27

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

171

2.94

11.27

1.1

1662.9

1513.1

miu/ml

0.35

171

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

154

850

1.84

11.26

1.2

53.1

39.9

u/ml

0.40

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

188

2.84

11.19

4.4

2.0

144.1

140.9

umol/l

0.03

105

(3020891) Body temperature

273

1764

1.58

11.13

5.7

4.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

106

3.51

11.11

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

464

2.13

11.11

1.4

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

143

3.09

10.84

1.1

—

(3011288) Drugs identified in Urine by Screen method

172

994

1.75

10.80

6.6

3.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

4200

39760

1.27

10.78

23.7

15.1

39.1

39.6

2.95

2914

28394

(3019225) pH of Specimen

581

4380

1.37

10.64

5.0

4.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

177

1037

1.73

10.60

2.6

3.5

—

(4010399)

420

2998

1.44

10.59

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

217

2.64

10.55

1.3

1.2

155.1

328.2

u/l

2.13

200

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

300

2010

1.52

10.41

1.6

1.7

1.6

1.5

g/l

0.51

251

1733

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

121

634

1.93

10.41

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

228

1438

1.61

10.31

2.4

2.2

0.6

1.0

g/l

1.40

202

1244

(1001926) Buprenorphine [Presence] in Urine by Screen method

191

1152

1.68

10.30

4.3

2.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

226

2.58

10.26

3.4

2.7

45.3

39.1

0.85

(3009214) Lutropin [Units/volume] in Serum or Plasma

184

1102

1.69

10.19

1.4

12.2

10.1

u/l

0.95

148

906

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

165

965

1.73

9.96

2.5

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

129

702

1.86

9.91

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

150

857

1.77

9.83

1.5

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

179

1077

1.69

9.76

1.3

3.7

6.7

u/ml

0.85

181

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

177

1062

1.69

9.75

1.3

1.2

7.5

6.0

u/ml

0.10

110

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

209

1312

1.62

9.66

2.2

2.0

37.8

37.6

g/l

0.16

182

1131

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

430

2.09

9.63

1.4

1.8

—

(3042517) Benzodiazepines panel - Urine

5.29

9.62

3.3

2.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

148

848

1.77

9.61

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1365

11631

1.23

9.61

4.0

3.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

191

1174

1.65

9.60

2.3

2.0

0.0

g/l

0.00

175

1074

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

143

2.95

9.59

3.6

2.7

31.6

28.7

umol/l

0.35

103

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.60

9.52

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

594

4580

1.33

9.35

4.0

3.5

—

(4198724)

169

2.74

9.16

7.9

3.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

187

1158

1.64

9.15

2.3

2.0

0.0

g/l

0.00

175

1073

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

149

870

1.73

9.09

1.2

5.1

u/ml

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

107

566

1.91

9.01

7.8

6.4

11.6

11.8

mg/l

0.16

519

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

230

2.45

8.93

15.6

11.9

0.6

mmol/l

0.05

214

(3024139) IgG subclass 3 [Mass/volume] in Serum

430

2.04

8.89

1.9

1.3

0.4

g/l

0.52

305

(3028192) IgG subclass 2 [Mass/volume] in Serum

430

2.04

8.89

1.9

1.3

2.9

g/l

0.02

304

(3027135) IgG subclass 1 [Mass/volume] in Serum

431

2.04

8.84

1.9

1.3

5.8

7.0

g/l

2.53

304

(3024891) Influenza virus A+B Ag [Presence] in Specimen

174

1073

1.64

8.67

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

248

3616

0.67

8.57

1.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

136

2.88

8.57

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

211

1368

1.56

8.55

4.2

2.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

201

1289

1.58

8.54

1.3

1.2

—

(3003338) MCHC [Mass/volume]

3907

36994

1.21

8.40

29.0

18.2

331.8

332.3

g/l

3.19

3882

36707

(4062490)

433

2.00

8.38

1.9

1.3

—

(3003181) Sodium [Moles/volume] in Urine

132

764

1.75

8.34

1.6

1.3

70.9

62.9

mmol/l

1.14

112

613

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

182

1147

1.61

8.33

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

441

1.99

8.32

3.5

3.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

132

766

1.74

8.26

1.4

119.8

114.9

u/ml

0.22

157

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

245

2.34

8.25

1.4

1.5

4.9

6.9

u/l

1.64

210

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

564

4399

1.32

8.17

2.2

2.1

—

(3051651) Icteric interference index of Serum or Plasma

253

2.31

8.13

3.6

3.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

253

2.31

8.13

1.1

15.4

10.9

iu/ml

0.29

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

483

3687

1.34

8.13

3.9

4.0

1.2

mmol/l

2.26

438

3229

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

145

868

1.69

8.12

1.2

—

(1761868) Lipid panel - Serum or Plasma

1307

15055

0.83

8.08

3.3

2.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

513

3955

1.33

8.07

2.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

267

1845

1.47

8.03

2.2

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

221

1472

1.52

7.95

4.1

2.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

167

1045

1.62

7.89

3.3

3.0

8.6

8.1

kpa

2.44

149

970

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

137

815

1.70

7.87

1.2

286.4

272.1

u/ml

0.21

507

(21494814) CD8 cells/100 lymphocytes in Specimen

178

2.54

7.81

1.7

2.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

250

1716

1.48

7.79

3.9

24.6

24.9

mmol/l

0.75

226

1584

(3028433) Virus identified in Specimen by Culture

138

2.77

7.78

1.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

191

1243

1.56

7.65

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

147

898

1.66

7.65

1.4

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

521

1.86

7.54

1.4

1.3

—

(3011985) Renin [Units/volume] in Plasma

101

558

1.83

7.50

1.9

1.4

74.9

55.5

mu/l

0.39

492

(3037121) Protein [Mass/volume] in Urine

223

1509

1.50

7.47

3.3

3.0

0.2

0.3

g/l

1.18

619

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

523

1.85

7.45

1.5

1.3

338.4

273.3

pmol/l

0.82

406

(3028300) Cannabinoids [Presence] in Urine

220

1487

1.50

7.41

4.1

2.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

158

992

1.61

7.39

1.4

—

(3027008) Opiates [Presence] in Urine

219

1480

1.50

7.38

3.1

2.1

—

(3027944) Amphetamines [Presence] in Urine

216

1456

1.50

7.37

4.1

2.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

667

5393

1.27

7.31

9.6

7.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

277

1967

1.43

7.25

2.0

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1626

14403

1.19

7.24

5.0

3.4

3.7

ug/l

0.10

1434

12901

(42529406) Shigella sp [Presence] in Stool by Culture

190

1252

1.54

7.22

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

320

2.08

7.18

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

320

2.08

7.18

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

229

2.28

7.17

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

321

2.07

7.12

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

321

2.07

7.12

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

321

2.07

7.12

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

187

1232

1.54

7.12

1.2

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

104

590

1.78

7.10

1.4

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

375

2814

1.36

7.08

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

322

2.06

7.07

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

518

1.83

7.06

1.4

1.3

—

nmol/l

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

143

888

1.63

7.01

4.0

3.7

57.5

57.7

0.08

143

888

(3007566) Smooth muscle Ab [Titer] in Serum

182

1197

1.54

6.99

1.2

97.0

95.3

titre

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

165

1062

1.57

6.97

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.86

6.97

1.1

—

(3022313) Gas panel - Capillary blood

278

1999

1.41

6.80

4.0

3.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

119

712

1.69

6.75

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.26

6.74

1.2

1.9

1.7

umol/24h

0.27

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

262

2.15

6.70

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

129

792

1.64

6.64

1.7

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

264

2.13

6.58

1.1

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

552

1.77

6.58

1.4

28.3

26.4

u/l

0.21

456

(4035726)

495

3907

1.29

6.56

1.5

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

331

2467

1.36

6.54

2.2

2.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

119

719

1.67

6.52

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

123

2.69

6.49

3.3

3.2

—

(40768443) Skin Pathology biopsy report

258

1853

1.41

6.37

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

249

2.14

6.30

1.4

1.5

—

(3012501) Base excess in Blood by calculation

158

1033

1.55

6.27

3.7

4.3

2.1

2.6

mmol/l

2.38

110

704

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

158

1033

1.55

6.27

1.6

1.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

205

2.25

6.22

1.1

16.6

26.2

u/ml

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

121

2.65

6.14

1.4

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

170

1139

1.51

6.04

1.1

6.8

u/ml

0.00

136

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.09

6.03

1.2

0.7

umol/24h

0.15

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.29

6.02

1.0

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

171

1149

1.50

6.00

3.3

3.2

24.7

24.9

mmol/l

0.25

146

1005

(3008898) HLA-B27 [Presence]

203

1413

1.45

5.97

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.82

5.97

1.2

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

577

1.71

5.94

1.9

2.0

4.0

2.3

titre

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

761

1.62

5.94

1.5

1.4

—

(3000492) Spirometry study

510

4095

1.27

5.91

1.6

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

249

2.10

5.91

1.1

1.0

ratio

0.04

(3013005) Retinol [Moles/volume] in Serum or Plasma

178

2.31

5.91

1.6

1.7

2.2

2.0

umol/l

0.80

167

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

142

2.47

5.84

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

212

2.18

5.77

1.1

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.61

5.75

1.8

1.9

—

(3017704) Immunofixation for Urine

226

2.13

5.71

1.1

1.6

—

(3045414) Leukocytes [Presence] in Urine

271

2002

1.37

5.70

1.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

181

2.27

5.70

1.6

1.7

6.1

7.4

nmol/l

0.09

150

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

467

1.77

5.61

1.8

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

396

3104

1.30

5.56

2.4

2.1

12.1

12.5

nmol/l

0.53

353

2722

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1303

11540

1.17

5.56

4.3

22.6

21.8

1.01

598

5705

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

4.25

5.55

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

101

612

1.66

5.54

1.6

—

(3010421) pH of Blood

176

1212

1.47

5.50

3.6

4.2

7.4

0.14

157

1017

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

591

1.65

5.23

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

189

2.18

5.17

7.2

3.2

—

(40767503) Oxygen content in Capillary blood by calculation

146

983

1.50

5.13

2.6

2.5

16.7

16.1

1.06

505

(3047007) Chlamydophila sp Ab [Presence] in Serum

582

1.64

5.03

1.3

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

559

1.66

5.03

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

170

2400

0.70

5.03

1.4

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.79

5.01

3.3

1.2

12.3

42.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

562

1.65

4.93

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

120

782

1.55

4.92

1.5

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

436

1.73

4.84

1.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

558

1.64

4.82

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

277

1.92

4.81

1.2

1.3

0.1

0.8

u/ml

1.20

129

(3023323) Follitropin [Units/volume] in Serum or Plasma

239

1782

1.36

4.79

1.5

1.4

29.4

28.1

iu/l

0.22

198

1528

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

202

2.09

4.79

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.07

4.78

1.0

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.75

4.77

1.6

2.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

386

1.77

4.76

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.88

4.75

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

387

1.77

4.73

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

387

1.77

4.73

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

387

1.77

4.73

1.5

1.7

—

(21494755) Public health laboratory ask at order entry panel

297

3805

0.77

4.66

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

563

1.63

4.66

1.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

121

2.40

4.63

1.6

1.9

16.2

57.3

u/l

1.27

113

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.91

4.59

1.2

1.9

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

437

3553

1.25

4.59

2.7

2.6

66.2

65.4

ml/min/173m2

0.17

189

1416

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

153

2.23

4.58

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

566

1.62

4.57

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

574

1.61

4.57

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

111

724

1.54

4.56

4.4

3.4

1.0

1.6

1.52

558

(3006922) Hepatitis E virus Ab [Presence] in Serum

311

1.84

4.56

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.06

4.51

2.7

1.2

77.9

49.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

105

679

1.56

4.49

1.5

1.4

—

(3034426) Prothrombin time (PT)

148

2.24

4.49

1.2

1.3

—

(1616796) Gas panel - Central venous blood

148

1029

1.45

4.47

3.0

3.7

—

(3003694) ABO and Rh group [Type] in Blood

1338

12042

1.15

4.47

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.93

4.43

1.5

1.3

—

(3002256) Pathology report gross observation

674

5748

1.20

4.43

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.01

4.43

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

128

867

1.49

4.42

1.5

1.6

—

(3021901) Oxygen saturation in Capillary blood

124

835

1.50

4.41

2.7

2.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

112

2.42

4.37

1.1

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

435

1.69

4.35

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

238

1.94

4.33

2.0

2.4

21.7

23.0

umol/l

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.34

4.32

1.1

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

132

2.28

4.28

1.2

0.3

g/l

0.40

103

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

289

1.84

4.27

1.1

1.0

—

(1002224) Polysomnography panel

216

1618

1.35

4.24

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

185

2.06

4.24

1.6

2.1

153.6

149.5

0.12

171

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

290

1.84

4.23

1.1

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

350

1.75

4.17

1.2

197.7

164.5

titre

0.13

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

167

2.10

4.12

1.2

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

301

1.80

4.07

3.8

2.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

266

1.85

4.02

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

149

2.15

4.01

1.7

1.9

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

325

1.76

3.99

1.0

1.1

—

13.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

144

1020

1.42

3.98

2.1

2.2

129.4

128.2

g/l

0.22

105

740

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

612

1.55

3.95

1.6

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

644

1.53

3.95

1.2

1.1

11.7

12.0

au/ml

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

298

1.79

3.90

1.0

31.7

45.1

ng/l

2.80

199

(3042111) Morphology [Interpretation] in Bone marrow Narrative

112

761

1.48

3.86

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

227

1.90

3.86

1.5

1.4

1.2

nmol/l

0.02

178

(3017732) Neutrophils [#/volume] in Blood

367

2988

1.25

3.85

3.2

3.0

4.6

4.1

e9/l

1.51

271

2321

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

443

1.63

3.84

1.1

1.2

—

(4015189)

113

2.31

3.84

1.8

2.3

—

(3025130) Human papilloma virus identified in Specimen

506

1.59

3.82

1.8

1.7

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

194

1.97

3.76

1.3

1.1

—

3.6

iu/ml

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

160

2.07

3.75

1.3

1.5

15.1

16.3

pmol/l

0.44

137

(44790047)

485

1.60

3.75

1.8

1.4

—

(44790049)

485

1.60

3.75

1.8

1.4

—

(44790048)

485

1.60

3.75

1.8

1.4

—

(44806118)

485

1.60

3.75

1.8

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

275

2172

1.28

3.73

1.1

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

104

702

1.49

3.72

1.3

1.2

41.2

45.7

u/l

0.07

608

(3051593) INR in Capillary blood by Coagulation assay

195

1.96

3.71

4.6

12.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

296

1.76

3.69

1.0

707.8

732.5

ng/l

0.13

195

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

103

695

1.49

3.69

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

542

4612

1.20

3.67

3.3

4.0

48.4

22.6

ug/l

0.48

443

3723

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

133

944

1.42

3.67

1.6

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

260

1.81

3.67

1.6

1.5

5.5

6.5

u/l

0.19

119

(3004616) Nuclear Ab [Presence] in Serum

506

1.57

3.60

1.3

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

623

5376

1.18

3.59

5.0

4.4

32.4

0.06

468

3617

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

329

1.71

3.57

1.3

1.2

47.2

47.7

u/ml

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.85

3.52

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

10.01

3.49

1.0

1.2

1.9

1.2

mg/l

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

10.01

3.49

1.3

2.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.70

3.48

1.6

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

441

3701

1.21

3.47

1.6

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

268

2133

1.27

3.44

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

418

1.61

3.42

3.0

2.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

593

1.51

3.42

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

427

1.60

3.39

3.9

3.7

—

(3016038) Potassium [Moles/volume] in Urine

297

1.72

3.38

1.3

1.2

30.1

35.9

mmol/l

1.07

257

(3045424) Erythrocytes [Presence] in Urine

106

735

1.45

3.35

1.3

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

653

1.48

3.34

1.3

1.2

—

(3022621) pH of Urine by Test strip

354

2920

1.23

3.32

3.5

3.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.72

3.32

1.2

1.3

234.6

68.5

ng/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

469

1.56

3.31

2.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.36

3.31

1.0

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

284

1.73

3.31

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

156

1162

1.35

3.26

3.7

3.6

1.5

mg/l

0.06

140

1060

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

8.58

3.26

1.3

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

278

1.73

3.25

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

142

1043

1.37

3.25

2.2

2.1

—

(3036603) Volume of Urine

279

1.73

3.22

1.9

1.5

1382.9

1828.2

1.46

(3044242) Glucose [Moles/volume] in Arterial blood

221

1.82

3.18

1.6

2.2

—

(3045716) Anion gap in Serum or Plasma

207

1.84

3.16

2.5

2.3

8.1

9.5

mmol/l

1.46

165

(40761536) Microorganisms panel - Urine sediment

444

3768

1.19

3.13

4.9

3.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.25

3.12

1.3

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

113

805

1.41

3.11

2.1

1.8

195.4

201.5

pmol/l

0.25

108

756

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

421

1.57

3.11

1.3

1.2

46.9

60.9

u/l

2.02

284

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

138

2.03

3.10

1.5

2.3

134885.7

21295.7

u/ml

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.23

3.05

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.23

3.05

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.23

3.05

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.23

3.05

1.0

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

447

1.55

3.05

5.2

3.4

60.5

57.9

0.33

278

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

121

877

1.39

3.02

3.2

1.8

0.8

nmol/l

0.13

102

734

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

161

1221

1.33

3.02

1.4

1.3

171.7

219.9

miu/ml

1.18

566

(3044927) Protein electrophoresis panel - Urine

433

1.55

3.00

1.3

1.2

—

(3006462) Nitrate [Presence] in Urine

219

1.79

2.96

3.7

3.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

734

6512

1.15

2.96

1.5

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

483

1.52

2.94

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

501

1.50

2.90

1.6

—

(3004451) EKG impression Narrative

221

1.77

2.88

1.2

—

(4094501)

153

1162

1.33

2.86

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

109

2.11

2.84

1.0

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.23

2.79

1.7

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

393

1.56

2.79

1.6

1.3

1.7

1.5

nmol/l

0.58

350

(3008295) Osmolality of Serum or Plasma

457

1.52

2.79

1.6

1.5

281.6

279.0

mosm/kgh2o

0.41

363

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

224

1.75

2.77

1.3

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

224

1.75

2.77

1.3

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

224

1.75

2.77

1.3

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

224

1.75

2.77

1.3

2.0

—

(4146454)

468

1.50

2.72

3.1

2.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.66

2.62

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

297

1.62

2.61

1.0

243.0

323.4

ng/l

2.71

202

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.15

2.60

3.0

2.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

120

2.00

2.60

1.4

1.9

—

(3005570) Glucose [Moles/volume] in Urine

449

1.50

2.59

2.3

1.9

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

137

1041

1.32

2.58

1.4

1.6

—

(3000330) Specific gravity of Urine by Test strip

273

2258

1.22

2.57

4.3

3.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.00

2.56

4.9

5.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

346

1.57

2.56

1.2

1.3

11.0

12.2

mmol/l

0.51

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.60

2.53

1.0

—

(3023419) Bacteria identified in Sputum by Culture

543

1.44

2.50

3.0

2.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

122

1.97

2.49

1.3

1.4

104.7

137.3

nmol/l

0.55

(3033705) Calcium.ionized [Moles/volume] in Venous blood

528

1.45

2.47

3.5

2.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

263

1.64

2.47

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

520

1.45

2.46

1.3

1.6

52.7

58.9

0.55

327

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

225

1.69

2.46

1.3

1.2

33.3

19.7

u/l

0.45

190

(3019977) pH of Arterial blood

248

1.66

2.45

2.0

2.5

7.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

534

4699

1.15

2.44

1.7

—

(3011648) Oxygen content in Venous blood

351

1.54

2.42

2.1

2.3

11.6

11.2

0.25

351

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

110

2.00

2.40

1.3

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

190

1.74

2.36

1.1

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

236

1.66

2.34

1.4

1.2

92.3

82.6

u/l

0.24

203

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

307

1.57

2.32

1.6

1.7

—

(4211845)

238

1.64

2.28

3.7

3.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

200

1.70

2.27

2.1

2.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

135

1.86

2.21

1.1

—

(3017569) Oxygen content in Arterial blood

217

1.66

2.21

1.7

2.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

259

2167

1.21

2.21

3.2

3.4

63.1

62.5

u/ml

0.01

252

2083

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.41

2.19

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.50

2.18

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

143

1.82

2.18

1.3

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.34

2.18

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

173

1.74

2.16

2.8

2.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.17

2.14

1.8

1.6

204.0

143.0

ng/l

0.40

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

362

1.50

2.14

1.4

1.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

144

1.81

2.14

1.4

2.0

9599.2

19345.1

e6/l

0.30

(3006270) Folate [Moles/volume] in Blood

388

1.47

2.10

1.2

1.1

343.8

359.6

nmol/l

0.26

335

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

102

1.96

2.10

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

2.56

2.09

2.0

1.4

mg/l

0.01

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.20

2.09

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

472

1.42

2.07

5.4

3.9

—

(40765096) Chromosome analysis panel by Banding

131

1.84

2.07

1.2

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

131

1.84

2.07

2.2

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

131

1.84

2.07

2.2

2.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

222

1.63

2.05

1.2

1.1

16.7

29.5

u/l

1.37

167

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

222

1.63

2.05

1.2

1.1

79.0

89.7

u/l

0.47

170

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

148

1177

1.26

2.05

1.3

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.00

2.04

2.0

3.5

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

4.00

2.04

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

125

1.84

2.02

3.7

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

312

1.51

1.97

1.4

1.5

21.7

21.6

u/ml

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

100

761

1.32

1.95

1.8

1.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

4.55

1.94

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.73

1.93

1.7

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

397

1.44

1.90

1.2

1.5

25.4

29.7

0.33

243

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

219

1.60

1.90

3.6

3.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

905

8349

1.10

1.90

2.8

3.0

0.8

ug/l

0.10

624

5638

(3040151) Glucose [Moles/volume] in Capillary blood

507

1.39

1.88

15.3

18.4

7.2

7.3

mmol/l

0.06

424

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

138

1718

0.80

1.88

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.31

1.87

1.0

1.3

—

(44806071)

2.31

1.87

1.2

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

665

1.33

1.82

1.1

151.6

910.1

iu/ml

0.45

152

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

175

1.66

1.82

1.2

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

175

1.66

1.82

1.2

2.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

294

1.50

1.81

1.4

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

190

1578

1.21

1.81

2.8

3.4

937.6

3534.4

u/ml

0.76

162

1344

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.76

1.79

3.9

8.2

—

(3030313) Adrenal Ab [Titer] in Serum

2.76

1.79

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

161

1.68

1.77

1.6

2.3

5595.0

693.8

e6/l

0.45

114

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

131

1.76

1.77

1.3

1.1

93.2

86.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

208

1.59

1.76

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

208

1.59

1.76

1.3

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

177

1.64

1.75

1.3

2.2

—

(40758292) HTLV I+II Ab panel - Serum

2.03

1.74

1.1

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

1.93

1.74

1.2

1.4

—

(40768446) Kidney Pathology biopsy report

162

1.67

1.74

1.7

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.50

1.73

1.0

1.2

8.3

19.9

u/l

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.85

1.71

1.0

1.3

—

mmol/l

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.80

1.65

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

186

1563

1.20

1.60

1.7

1.6

—

(3014271) Vancomycin [Susceptibility]

222

1.53

1.59

2.8

2.9

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.00

1.58

1.0

1.1

—

(21494434) Karyotype in Bone marrow

389

1.39

1.55

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

129

1050

1.23

1.54

1.6

1.7

12289.4

12523.6

e6/l

0.02

100

755

(3032057) Clostridioides difficile [Presence] in Stool

100

1.80

1.52

1.4

2.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.34

1.52

1.2

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

161

1.62

1.52

2.9

2.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

394

1.37

1.45

3.0

4.8

239.0

73.9

u/ml

0.87

104

(3024471) HLA-A [Type]

132

1.67

1.45

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

228

1.49

1.43

2.2

2.1

43.8

226.7

ug/min

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

466

1.33

1.40

2.4

2.2

5.0

6.7

umol/l

1.31

341

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.08

1.38

1.7

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

142

1.62

1.38

1.6

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.20

1.36

1.2

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

127

1.66

1.36

1.1

1.3

—

(3048879) Bone marrow aspiration report

127

1.66

1.36

1.4

2.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

583

1.29

1.34

1.4

0.4

nmol/l

0.38

466

(3020393) Adenovirus Ag [Presence] in Stool

2.13

1.33

1.2

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

584

1.29

1.33

1.1

1.5

g/l

0.02

525

(3027456) Digoxin [Moles/volume] in Serum or Plasma

108

879

1.23

1.33

3.2

3.1

0.8

nmol/l

1.42

675

(21494890) Protein electrophoresis panel - 24 hour Urine

453

1.33

2.2

2.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

144

1.60

1.31

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

897

0.78

1.30

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

351

1.37

1.30

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

896

0.78

1.30

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

201

1.50

1.29

25.5

24.9

129.6

112.9

ug/l

0.59

162

(3022493) Free Hemoglobin [Mass/volume] in Plasma

169

1.54

1.28

4.4

3.8

81.9

70.2

mg/l

0.37

119

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

894

0.78

1.28

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

114

1.67

1.28

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

396

1.34

1.27

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

2.05

1.26

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

892

0.78

1.26

1.4

—

(3021788) Differential panel - Synovial fluid

786

1.24

1.25

1.4

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

563

1.28

1.25

1.1

2.5

3.3

u/ml

0.28

260

(40757373) Influenza virus identified in Isolate

1.74

1.24

1.8

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

261

1.42

1.24

1.4

1.6

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.40

1.24

1.0

45.7

61.1

u/l

—

(3025315) Body weight

2.40

1.24

4.2

4.3

—

(3050794) Legionella sp Ab [Presence] in Serum

2.22

1.24

1.1

—

(3042733) HLA Ab [Presence] in Serum

131

1.61

1.23

4.1

4.8

—

(3033799) Differential panel - Peritoneal fluid

139

1.59

1.23

1.5

2.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.04

1.22

1.0

—

(3017509) Phencyclidine [Presence] in Urine

2.16

1.21

4.1

1.7

—

(3042631) Mycobacterium sp identified in Specimen

594

1.27

1.19

2.6

2.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1104

0.81

1.18

1.5

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

111

923

1.21

1.14

2.9

3.3

174.5

771.2

u/ml

1.14

100

844

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

554

1.27

1.13

2.2

32.7

32.5

0.14

549

(3019174) dRVVT (LA screen)

2.00

1.12

1.4

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

415

1.30

1.10

1.4

245551.6

125159.0

e6/l

0.32

285

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

260

1.39

1.09

1.4

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

639

0.76

1.09

1.6

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

328

0.67

1.08

1.0

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

514

0.74

1.08

2.8

2.9

13.2

0.18

509

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.95

1.08

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

425

1.30

1.08

1.4

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

971

0.81

1.08

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

191

0.58

1.03

1.1

1.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.74

1.02

1.5

4.2

7.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

342

1.32

1.01

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.88

1.00

1.0

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.00

1.00

1.1

—

42.8

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.62

0.99

1.3

1.4

22.0

25.3

g/l

—

(3024932) HLA-DR beta [Type]

132

1.52

0.96

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

132

1.52

0.96

1.3

100.6

83.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

116

1.55

0.96

1.4

1.3

46.9

32.3

—

(4034850)

163

1426

1.15

0.96

9.4

10.1

—

(3035880) pH of Pleural fluid

250

1.36

0.95

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

736

0.80

0.95

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

149

1.48

0.95

1.0

1.2

—

0.2

g/l

—

(3045142) Bone marrow Pathology biopsy report

497

1.25

0.94

1.4

1.3

—

(3044007) Cell count panel - Peritoneal fluid

133

1.51

0.94

1.8

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

756

0.80

0.93

1.4

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

109

1.56

0.93

1.0

—

(3005033) Fetal Nuchal fold Thickness US

733

0.80

0.92

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.14

0.91

1.3

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.67

0.91

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.60

0.90

1.1

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

187

1.39

0.85

1.2

1.0

—

(3020491) Glucose [Moles/volume] in Blood

335

1.29

0.84

2.0

2.3

8.5

6.6

mmol/l

1.70

225

(3027035) Albumin [Mass/time] in 24 hour Urine

1.74

0.82

1.4

1.3

—

640.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.69

0.82

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

971

0.84

0.82

4.1

3.4

22.8

27.4

mg/l

0.54

613

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

124

1082

1.15

0.79

1.3

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

114

1.49

0.79

1.0

1.1

0.3

1.7

u/ml

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

385

0.75

0.79

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

611

1.20

0.78

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

292

0.72

0.77

1.2

1.4

84.9

153.9

pmol/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

115

1.48

0.76

5.1

7.3

—

(3044941) Cell count panel - Synovial fluid

696

1.18

0.75

1.3

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

513

1.21

0.75

1.6

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

124

1.45

0.75

1.7

—

(3044009) aPTT.lupus sensitive (LA screen)

1.84

0.73

1.4

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.84

0.73

3.3

2.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

100

1.50

0.72

1.3

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.61

0.72

1.1

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

785

0.84

0.72

1.4

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.75

0.71

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

827

0.84

0.71

1.5

—

(3022475) Manganese [Moles/volume] in Blood

1.92

0.70

1.0

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

426

1.22

0.70

1.1

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

127

1123

1.13

0.70

5.9

4.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.55

0.69

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

249

1.29

0.67

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.49

0.66

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.49

0.66

1.6

2.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.61

0.65

1.0

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

103

1.46

0.64

2.1

2.2

6.6

7.7

mmol/l

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.72

0.64

2.4

1.3

347.6

347.3

umol/24h

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

216

1.30

0.63

1.1

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

162

1466

1.11

0.62

1.7

1.9

—

(4133840)

104

1.44

0.62

1.3

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.67

0.61

4.0

4.4

2.4

2.5

mg/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

572

1.17

0.61

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

535

1.18

0.61

2.5

2.1

25.4

21.8

mg/l

0.20

129

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

325

1.23

0.60

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

611

1.16

0.59

1.0

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.59

0.0

1.3

—

4686.8

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.58

0.0

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.48

0.57

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

689

1.15

0.56

1.1

3.7

5.2

u/ml

0.38

344

(3045462) Protein/Creatinine [Ratio] in Urine

1.54

0.53

2.5

3.6

114.6

34.0

g/mol

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

178

1.29

0.52

1.3

1.5

67.0

64.9

0.11

145

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.43

0.52

1.8

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

404

3832

1.06

0.51

1.5

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.41

0.51

4.7

5.6

—

(3012898) Urea [Moles/volume] in Urine

1.46

0.50

1.5

1.3

166.7

165.9

mmol/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

279

1.22

0.49

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

110

1.36

0.48

1.1

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.45

0.48

1.1

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.61

0.45

1.4

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.61

0.45

2.8

6.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

817

1.12

0.45

2.9

3.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

609

1.13

0.45

1.4

1.5

31.3

32.3

g/l

0.29

553

(3024263) Appearance of Synovial fluid

247

1.22

0.44

1.1

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

130

1.31

0.43

1.7

1.5

10.5

8.5

ug/l

0.64

130

(3020874) Milk IgE Ab [Units/volume] in Serum

229

1.22

0.43

1.1

1.0

0.3

3.1

u/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.41

0.43

5.9

7.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

661

1.12

0.41

1.1

1.2

1.1

u/ml

0.01

269

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.52

0.41

2.2

3.9

—

(40760410) HLA-B [Type] by High resolution

0.00

0.41

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.41

0.0

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.47

0.40

1.6

3.5

—

0.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

141

1.28

0.40

1.0

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.40

0.0

1.0

—

(3025577) Chromium [Mass/volume] in Blood

269

1.19

0.39

1.7

2.1

1.8

2.2

ug/l

0.76

225

(40758358) Immune stain study

0.00

0.39

0.0

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

116

1067

1.09

0.38

2.3

2.4

83.2

111.7

ug/min

0.49

650

(3001556) Androgen free Index in Serum or Plasma

1.39

0.38

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

170

0.76

0.38

1.8

2.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

618

1.12

0.38

1.2

1.1

2.1

2.3

u/ml

0.05

151

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

215

1.21

0.38

4.1

4.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.33

0.37

5.9

7.8

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.35

0.37

1.2

1.1

—

9.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

137

1274

1.08

0.36

1.4

1.5

—

(44813793)

291

1.17

0.35

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.43

0.35

2.2

2.5

0.3

0.6

u/field

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.40

0.35

3.3

2.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

146

1364

1.07

0.34

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

265

0.83

0.34

1.5

7.2

8.0

mmol/l

1.63

162

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

220

1.18

0.31

1.2

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

220

1.18

0.31

1.2

1.5

—

(3047189) Immunofixation for 24 hour Urine

212

1.18

0.30

2.6

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.25

0.29

3.9

10.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.25

0.29

1.3

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

141

0.78

0.29

2.3

1.8

—

(3045788) Cell count panel - Pleural fluid

420

1.12

0.29

1.7

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

556

0.90

0.29

1.4

1.3

8.3

7.3

mmol/l

0.85

406

(3037556) Urate [Mass/volume] in Serum or Plasma

130

1.23

0.28

1.6

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.25

0.27

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.25

0.27

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.25

0.27

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

356

1.12

0.27

1.4

2.1

3.9

1.7

u/field

0.69

141

(3012441) Differential panel - Pleural fluid

461

1.11

0.27

1.5

—

(4281824)

454

1.10

0.25

1.2

—

(40768793) Breast Pathology biopsy report

102

960

1.06

0.23

1.2

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.28

0.23

1.0

5.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

670

1.08

0.22

1.4

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

314

1.12

0.22

1.7

1.5

0.9

1.0

g/l

0.05

314

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

700

0.93

0.22

3.1

3.7

28.9

31.6

u/ml

0.13

678

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

230

0.87

0.21

1.3

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

4.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.3

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

306

1.11

0.20

2.5

1.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

134

0.82

0.20

1.4

1.2

44.5

39.3

g/l

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.25

0.20

1.5

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

451

1.09

0.20

1.6

1.4

5.1

4.1

ug/l

0.15

398

(3028308) Erythrocytes [#/volume] in Pleural fluid

480

1.08

0.20

1.6

1.4

12767.6

77442.2

e6/l

2.87

286

(3023199) Leukocytes [#/volume] in Pleural fluid

539

1.08

0.19

1.5

1526.6

1884.6

e6/l

0.34

394

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.15

0.19

1.0

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.15

0.19

11.8

13.5

5.0

5.6

mmol/l

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.15

0.19

1.0

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

492

1.08

0.18

1.1

4.1

4.7

u/ml

0.11

190

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

233

1.12

0.17

1.5

1.3

5.6

5.8

mmol/l

0.66

222

(3014599) Egg white IgE Ab [Units/volume] in Serum

224

1.12

0.17

1.0

0.3

0.7

u/ml

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.76

0.17

1.4

1.6

—

(40768795) Lymph node Pathology biopsy report

432

0.93

0.16

1.1

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

235

0.89

0.16

1.6

1.7

1.6

3.6

u/field

1.12

169

(4024509)

438

1.07

0.15

1.3

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

420

1.07

0.14

2.4

3.2

17.6

37.1

mg/l

1.70

316

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

223

0.90

0.14

1.8

1.5

—

(40768806) Pleura Pathology biopsy report

481

0.94

0.14

1.5

1.6

—

(40768800) Prostate Pathology biopsy report

940

0.96

0.14

1.1

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

133

1.13

0.12

1.7

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

220

1.09

0.11

1.1

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

730

0.96

0.11

1.6

1.7

—

(3022689) Creatine [Moles/volume] in Urine

136

0.88

0.11

1.2

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

115

1.13

0.10

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

144

1.11

0.10

1.4

1.5

0.7

2.9

2.44

123

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.14

0.10

2.2

2.7

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.11

0.09

2.2

1.2

4.3

4.7

nmol/l

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.11

0.09

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.04

0.09

1.8

2.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

227

0.92

0.09

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.13

0.09

1.1

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

263

1.06

0.08

4.8

6.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

154

1508

1.02

0.08

1.7

4.2

4.1

mg/l

0.04

122

1057

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.03

0.07

1.4

2.7

—

(3004775) Volume in Urine collected for unspecified duration

353

1.05

0.07

2.3

2.2

660.4

628.2

0.18

236

(3029396) Erythrocyte agglutination [Presence] in Blood

1.02

0.07

1.6

2.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

216

1.07

0.06

1.3

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

542

1.03

0.06

1.1

3.9

3.5

u/ml

0.06

201

(3001019) Free T4 and TSH panel - Serum or Plasma

207

2097

0.99

0.05

1.4

1.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.10

0.04

1.4

1.2

2.2

1.6

mmol/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

170

1.06

0.04

1.0

1.1

—

(40768441) Liver Pathology biopsy report

329

1.03

0.03

1.5

1.4

—

(44806420)

132

1.06

0.02

2.4

2.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

773

1.01

0.01

1.2

1.1

0.3

1.3

u/ml

3.41

288

(3016750) Collection duration of Urine

256

0.98

0.00

2.0

2.1

503.6

488.6

min

0.50

191

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

324

1.02

0.00

1.2

1.3

11.6

13.2

u/l

0.31

299

(3020650) Glucose [Presence] in Urine

115

1.04

0.00

1.3

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

448

1.00

0.00

1.1

0.0

0.4

u/ml

2.36

102

(3000012) Reticulocyte production index

235

0.98

0.00

1.6

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

114

0.96

0.00

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.96

0.00

1.8

2.2

—

(3000285) Sodium [Moles/volume] in Blood

1.02

0.00

1.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.95

0.00

1.3

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1432.9

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.3

—

110.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

5.7

—

0.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.2

—

2.6

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

5.7

—

56.3

—

(3014891) Appearance of Pleural fluid

0.97

0.00

1.8

1.7

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

115.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

37.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_DIPLOPIA and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_DIPLOPIA	1.261 [1.14, 1.39]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.297

During the follow-up period (1.1.1998 — 31.12.2019), 2368 out of 13939 females with H7_DIPLOPIA died.

Males

Parameter	HR [95% CI]	p-value
H7_DIPLOPIA	1.231 [1.11, 1.36]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 2994 out of 13545 males with H7_DIPLOPIA died.

Mortality risk

Mortality risk for people of age

years, who have H7_DIPLOPIA.

N-year risk	Females	Males
1	0.156%	0.261%
5	0.883%	1.563%
10	2.033%	3.62%
15	3.659%	6.976%
20	6.374%	11.805%

Relationships between endpoints

↥

Index endpoint: H7_DIPLOPIA – Diplopia

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Diplopia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints